<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Neuromuscul Dis</journal-id>
<journal-id journal-id-type="iso-abbrev">J Neuromuscul Dis</journal-id>
<journal-id journal-id-type="publisher-id">JND</journal-id>
<journal-title-group>
<journal-title>Journal of Neuromuscular Diseases</journal-title>
</journal-title-group>
<issn pub-type="ppub">2214-3599</issn>
<issn pub-type="epub">2214-3602</issn>
<issn-l>2214-3599</issn-l>
<publisher>
<publisher-name>IOS Press</publisher-name>
<publisher-loc>Nieuwe Hemweg 6B, 1013 BG Amsterdam, The Netherlands</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32176652</article-id>
<article-id pub-id-type="pmc">7369045</article-id>
<article-id pub-id-type="publisher-id">JND190459</article-id>
<article-id pub-id-type="doi">10.3233/JND-190459</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Is Gene-Size an Issue for the Diagnosis of Skeletal Muscle Disorders?</article-title>
<alt-title alt-title-type="left-running-head">M. Savarese et al.</alt-title>
<alt-title alt-title-type="right-running-head">Is Gene-Size an Issue for the Diagnosis of Skeletal Muscle Disorders?</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Savarese</surname>
<given-names>Marco</given-names>
</name>
<xref ref-type="aff" rid="aff1">a</xref>
<xref ref-type="aff" rid="aff2">b</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Välipakka</surname>
<given-names>Salla</given-names>
</name>
<xref ref-type="aff" rid="aff1">a</xref>
<xref ref-type="aff" rid="aff2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Johari</surname>
<given-names>Mridul</given-names>
</name>
<xref ref-type="aff" rid="aff1">a</xref>
<xref ref-type="aff" rid="aff2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hackman</surname>
<given-names>Peter</given-names>
</name>
<xref ref-type="aff" rid="aff1">a</xref>
<xref ref-type="aff" rid="aff2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Udd</surname>
<given-names>Bjarne</given-names>
</name>
<xref ref-type="aff" rid="aff1">a</xref>
<xref ref-type="aff" rid="aff2">b</xref>
<xref ref-type="aff" rid="aff3">c</xref>
<xref ref-type="aff" rid="aff4">d</xref>
</contrib>
<aff id="aff1">
<label>a</label>
<institution>Folkhälsan Research Center</institution>, Helsinki, <country>Finland</country>
</aff>
<aff id="aff2">
<label>b</label>Department of Medical Genetics, Medicum, <institution>University of Helsinki</institution>, Helsinki, <country>Finland</country>
</aff>
<aff id="aff3">
<label>c</label>Neuromuscular Research Center, <institution>Tampere University and University Hospital</institution>, Tampere, <country>Finland</country>
</aff>
<aff id="aff4">
<label>d</label>Department of Neurology, <institution>Vaasa Central Hospital</institution>, Vaasa, <country>Finland</country>
</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>Correspondence to: Marco Savarese, Ph.D., Folkhälsan Institute of Genetics, Department of Medical Genetics, University of Helsinki, Biomedicum, Haartmaninkatu 8 -Pb 63 00014 Helsinki–Finland. Tel.: +358 294125069; E-mail: <email>marco.savarese@helsinki.fi</email>.
</corresp>
</author-notes>
<pub-date date-type="preprint" publication-format="electronic">
<day>11</day>
<month>3</month>
<year>2020</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>02</day>
<month>6</month>
<year>2020</year>
</pub-date>
<pub-date date-type="collection" publication-format="electronic">
<year>2020</year>
</pub-date>
<volume>7</volume>
<issue>3</issue>
<fpage>203</fpage>
<lpage>216</lpage>
<permissions>
<copyright-statement>© 2020 – IOS Press and the authors. All rights reserved</copyright-statement>
<copyright-year>2020</copyright-year>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License</ext-link>, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<abstract>
<p>Human genes have a variable length. Those having a coding sequence of extraordinary length and a high number of exons were almost impossible to sequence using the traditional Sanger-based gene-by-gene approach. High-throughput sequencing has partly overcome the size-related technical issues, enabling a straightforward, rapid and relatively inexpensive analysis of large genes.</p>
<p>Several large genes (e.g. <italic>TTN, NEB</italic>, <italic>RYR1</italic>, <italic>DMD</italic>) are recognized as disease-causing in patients with skeletal muscle diseases. However, because of their sheer size, the clinical interpretation of variants in these genes is probably the most challenging aspect of the high-throughput genetic investigation in the field of skeletal muscle diseases.</p>
<p>The main aim of this review is to discuss the technical and interpretative issues related to the diagnostic investigation of large genes and to reflect upon the current state of the art and the future advancements in the field.</p>
</abstract>
<kwd-group>
<label>Keywords</label>
<kwd>Large genes</kwd>
<kwd>variant interpretation</kwd>
<kwd>genetic diagnosis</kwd>
<kwd>variants of uncertain significance (VUS)</kwd>
<kwd>copy number variants (CNV)</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec0005">
<title>INTRODUCTION</title>
<p>Human protein-coding genes have a variable length, ranging from a few hundred nucleotides up to several millions [<xref ref-type="bibr" rid="ref001">1, 2</xref>]. Most of the large genes, e.g. <italic>DMD</italic>, have introns with an extraordinary length [<xref ref-type="bibr" rid="ref002">2, 3</xref>]. Some other genes have adapted with evolution, reducing the size of their introns to have a higher transcriptional efficiency [<xref ref-type="bibr" rid="ref004">4, 5</xref>]. <italic>TTN</italic> gene, for example, has evolved through many gene duplication events by reducing the size of its introns and thus optimizing its transcription [<xref ref-type="bibr" rid="ref006">6</xref>].</p>
<p>Large genes have been reported to be enriched in pathways linked to cancer or other human diseases, including cardiomyopathy and skeletal muscle diseases [<xref ref-type="bibr" rid="ref004">4</xref>]. To study the genes with a long coding sequence and a large number of exons, the traditional Sanger sequencing was an extremely expensive, time consuming and laborious approach. This technical bias has hampered a proper investigation of these genes for diagnostic purposes, reducing the number of variants identified and hampering a correct diagnosis in probably thousands of patients.</p>
<p>The rapid and thorough investigation of multiple genes, made possible by the introduction of high throughput sequencing (HTS), has allowed the analysis of large genes. The use of HTS has also resulted into a growing number of variants identified in these genes and in an increased diagnostic yield [<xref ref-type="bibr" rid="ref007">7–9</xref>], expanding the spectrum of diseases associated with large-genes [<xref ref-type="bibr" rid="ref010">10–14</xref>].</p>
<p>Here, we will briefly review the findings related to the three skeletal muscle disease-genes with the longest coding sequence (<xref ref-type="table" rid="jnd-7-jnd190459-t001">Table 1</xref>) [<xref ref-type="bibr" rid="ref015">15</xref>]. We will then discuss the technical and interpretative difficulties, related to the sheer size of these genes, met during the diagnostic workflow (<xref ref-type="fig" rid="jnd-7-jnd190459-g001">Fig. 1</xref>). Finally, we will mention the advancements in the field and the possible outcome of the recently developed, cutting-edge sequencing technologies soon to be used in a diagnostic setting.</p>
<table-wrap id="jnd-7-jnd190459-t001" orientation="portrait" position="float">
<label>Table 1</label>
<caption>
<p>Large genes causing a skeletal muscle disease</p>
</caption>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
<col align="center" span="1"/>
</colgroup>
<thead valign="top">
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">Coding exons</td>
<td colspan="1" rowspan="1">Reference transcript ID<sup>*</sup></td>
<td colspan="1" rowspan="1">Size of the coding sequence<sup>#</sup></td>
</tr>
</thead>
<tbody>
<tr>
<td colspan="1" rowspan="1">
<italic>TTN</italic>
</td>
<td colspan="1" rowspan="1">363</td>
<td colspan="1" rowspan="1">NM_001267550.1</td>
<td colspan="1" rowspan="1">107976</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
<italic>NEB</italic>
</td>
<td colspan="1" rowspan="1">183</td>
<td colspan="1" rowspan="1">NM_001271208.1</td>
<td colspan="1" rowspan="1">25683</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
<italic>RYR1</italic>
</td>
<td colspan="1" rowspan="1">106</td>
<td colspan="1" rowspan="1">NM_000540.2</td>
<td colspan="1" rowspan="1">15117</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
<italic>PLEC</italic>
</td>
<td colspan="1" rowspan="1">32</td>
<td colspan="1" rowspan="1">NM_000445.3</td>
<td colspan="1" rowspan="1">13725</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
<italic>DMD</italic>
</td>
<td colspan="1" rowspan="1">79</td>
<td colspan="1" rowspan="1">NM_004006.2</td>
<td colspan="1" rowspan="1">11058</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
<italic>SPEG</italic>
</td>
<td colspan="1" rowspan="1">41</td>
<td colspan="1" rowspan="1">NM_005876.4</td>
<td colspan="1" rowspan="1">9804</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
<italic>COL12A1</italic>
</td>
<td colspan="1" rowspan="1">66</td>
<td colspan="1" rowspan="1">NM_004370.5</td>
<td colspan="1" rowspan="1">9192</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><sup>*</sup>As listed in the Leiden Database. <sup>#</sup>longest transcript.</p>
</table-wrap-foot>
</table-wrap>
<fig id="jnd-7-jnd190459-g001" orientation="portrait" position="float">
<label>Fig. 1</label>
<caption>
<p>–Gene-size related difficulties. Three are the main issues related to the diagnostic investigation of large genes: the technical issues due to the presence of repetitive sequences and the subsequent mapping difficulties; the biological issues due to alternative splicing events resulting in isoforms with a different expression; the interpretative issues related to the clinical interpretation of the high number of rare variants identified in large genes.</p>
</caption>
<graphic xlink:href="jnd-7-jnd190459-g001"></graphic>
</fig>
</sec>
<sec id="sec0010">
<title>THE TITIN GENE, <italic>TTN</italic></title>
<p>The 363-coding exon <italic>TTN</italic> gene encodes titin, the largest known human protein [<xref ref-type="bibr" rid="ref016">16</xref>]. Titin plays several crucial structural and functional roles in the muscle through a wide network of interactions and interactors [<xref ref-type="bibr" rid="ref017">17</xref>]. <italic>TTN</italic> mutations are responsible for a wide spectrum of skeletal muscle disorders with or without an overt cardiac involvement [<xref ref-type="bibr" rid="ref017">17</xref>]. Skeletal muscle titinopathies are mainly recessive and include congenital myopathies and proximal or distal myopathies with a later onset [<xref ref-type="bibr" rid="ref017">17–19</xref>]. Mutations in the last exons can result in a dominant form, the Tibial Muscular Dystrophy, a late onset distal myopathy [<xref ref-type="bibr" rid="ref020">20</xref>]. Missense mutations in a specific exon (exon 344) have been associated with an adult onset hereditary myopathy with early respiratory failure (HMERF) [<xref ref-type="bibr" rid="ref021">21, 22</xref>].</p>
</sec>
<sec id="sec0015">
<title>THE NEBULIN GENE, <italic>NEB</italic></title>
<p>With its 183 exons, <italic>NEB</italic> encodes nebulin, a big protein of 600–900 kDa [<xref ref-type="bibr" rid="ref023">23</xref>]. Nebulin has a highly repetitive structure and can bind hundreds of actin monomers, thereby regulating the length of actin filaments and their interaction with myosin [<xref ref-type="bibr" rid="ref023">23</xref>].</p>
<p><italic>NEB</italic> mutations are the most common cause of autosomal recessive congenital nemaline myopathy, but onset may range from the severe forms with a perinatal onset to milder forms with a later onset [<xref ref-type="bibr" rid="ref024">24</xref>].</p>
<p>However, recessive disease-causing variants in <italic>NEB</italic> have been identified also in patients with a distal myopathy [<xref ref-type="bibr" rid="ref025">25, 26</xref>], core rod myopathy [<xref ref-type="bibr" rid="ref027">27</xref>], and fetal akinesia/lethal multiple pterygium syndrome [<xref ref-type="bibr" rid="ref012">12, 28</xref>]. <italic>NEB</italic> with its 32-kb triplicate region (eight exons repeated three times: 82–89, 90–97, 98–105) is prone to copy number variants (CNV) [<xref ref-type="bibr" rid="ref029">29</xref>]. Moreover, recently, Kiiski and colleagues described a large in-frame deletion, dominantly inherited in a three-generation family, causing a distal nemaline/cap myopathy [<xref ref-type="bibr" rid="ref030">30</xref>].</p>
</sec>
<sec id="sec0020">
<title>THE RYANODINE RECEPTOR GENE, <italic>RYR1</italic></title>
<p><italic>RYR1</italic> gene encodes ryanodine receptor 1, an intracellular channel responsible for the release of Ca2+ from sarcoplasmic reticulum [<xref ref-type="bibr" rid="ref031">31</xref>].</p>
<p><italic>RYR1</italic> mutations cause a wide spectrum of dominant and recessive myopathies [<xref ref-type="bibr" rid="ref032">32</xref>]. <italic>RYR1</italic>-related myopathies are usually classified in several histological subtypes, including central core disease, multiminicore disease, core–rod myopathy, centronuclear myopathy and congenital fiber-type disproportion [<xref ref-type="bibr" rid="ref033">33–37</xref>]. Moreover, <italic>RYR1</italic> mutations are a well-known cause of dominant malignant hyperthermia (MH) susceptibility [<xref ref-type="bibr" rid="ref038">38</xref>], and of exercise-induced rhabdomyolysis [<xref ref-type="bibr" rid="ref039">39</xref>]. Recently, a calf-predominant myopathy with core pathology was associated with dominantly inherited <italic>RYR1</italic> mutations [<xref ref-type="bibr" rid="ref014">14</xref>].</p>
</sec>
<sec id="sec0025">
<title>ALTERNATIVE SPLICING EVENTS AND MULTIPLE ISOFORMS</title>
<p>Large multi-exonic genes undergo extensive alternative splicing events in different developmental and physiological states [<xref ref-type="bibr" rid="ref040">40</xref>]. Alternative splicing is a highly regulated process by which a single gene produces multiple distinct mRNA isoforms and protein variants of different size [<xref ref-type="bibr" rid="ref040">40</xref>].</p>
<p>Although <italic>TTN</italic> transcripts have traditionally been classified in six main isoforms [<xref ref-type="bibr" rid="ref016">16</xref>], we and other groups have described a more complex splicing pattern with an elevated number of alternative splicing events, resulting into exon skipping events and the use of alternative 5<sup>′</sup> and 3<sup>′</sup> splice sites. During the prenatal development, larger and more compliant titin isoforms are expressed. A perinatal switch in titin isoforms leads to the production of shorter transcripts [<xref ref-type="bibr" rid="ref041">41</xref>], resulting into a smaller and less compliant protein expressed in the later period of life [<xref ref-type="bibr" rid="ref042">42</xref>]. Interestingly, <italic>TTN</italic> mutations located in exons with a higher fetal expression, result into a form of arthrogryposis multiplex congenita characterized by reduced fetal movements and a congenital amyoplasia and severe hypotonia [<xref ref-type="bibr" rid="ref019">19</xref>]. A different expression of specific exons among anatomically different muscles is also expected although the experimental setting of our recent study on titin splicing in adult skeletal muscles did not allow us to observe any clear splicing difference among the anatomically different muscles [<xref ref-type="bibr" rid="ref043">43</xref>].</p>
<p>A complex splicing pattern has also been reported for <italic>NEB</italic>. In particular, specific regions of the gene (exons 63–66; exons 143–144; exons 167–177) undergo extensive alternative splicing. A study performed by Laitila and colleagues combining expression array and RT-PCR data suggests that anatomically different muscles do not show specific <italic>NEB</italic> isoforms [<xref ref-type="bibr" rid="ref044">44</xref>]. <italic>NEB</italic> splicing is also developmentally-regulated, resulting in different isoforms with potentially different functional roles [<xref ref-type="bibr" rid="ref045">45</xref>].</p>
<p>In <italic>RYR1</italic>, a fetal isoform (ASI-) lacks residues 3481–3485 in exon 70 [<xref ref-type="bibr" rid="ref046">46</xref>]. The alternative splicing of this region plays an important role in adapting to different physiological and pathological conditions [<xref ref-type="bibr" rid="ref047">47</xref>].</p>
<p>A number of RNA-binding proteins act as splicing regulators, determining the isoform expression of large genes. The muscle-specific splicing factor RBM20 is responsible for <italic>TTN</italic> alternative splicing [<xref ref-type="bibr" rid="ref041">41, 48</xref>] and it targets other several important genes, including cardiomyopathy and skeletal muscle disease-related genes (e.g. <italic>CACNA1c</italic>, <italic>RYR2</italic>, <italic>LDB3</italic>, <italic>DAB1</italic>, <italic>CAMK2D</italic> and <italic>SPEN</italic>) [<xref ref-type="bibr" rid="ref049">49</xref>]. Similarly, CUG binding protein 1 (CUG-BP1) regulates the alternative splicing of RYR1 [<xref ref-type="bibr" rid="ref047">47</xref>].</p>
<p>A better understanding of these events and a further characterization of the splicing regulators will probably provide new insight in the pathogenesis of human diseases and, probably, novel potential pharmaceutical and therapeutic targets.</p>
</sec>
<sec id="sec0030">
<title>THE INTERPRETATION OF RARE VARIANTS IN LARGE GENES</title>
<p>Because of their sheer size, rare variants in large genes are observed almost in any test able to investigate these genes. The evaluation of the clinical meaning of these variants is a challenging multi-step process based on specific criteria, as suggested by the ACMG/AMP guidelines [<xref ref-type="bibr" rid="ref050">50</xref>]. These guidelines represent a general framework and their application to large genes does not allow a straightforward distinction between the few causative mutations and the large number of rare, clinically irrelevant, variants. Thereby, clinical geneticists report most of these experimentally identified rare variants as variants of uncertain significance (VUS).</p>
<p>When interpreting variants in large genes, a 'deep phenotyping' is crucial to identify a correlation between the observed phenotype and the known gene-associated clinical presentations [<xref ref-type="bibr" rid="ref051">51</xref>]. The recent large HTS-based studies are further expanding the already broad range of clinical phenotypes associated to the genes discussed in this review [<xref ref-type="bibr" rid="ref013">13, 14, 19</xref>]. Traditionally, the diagnosis of skeletal muscle disorders benefits from a careful evaluation of clinical signs and symptoms, of creatine kinase level, of histopathological findings on a muscle biopsy and of electromyography records. However, each of the aforementioned tests does not have enough specificity to discriminate among the different genetic forms. A comprehensive diagnostic approach and analysis is thereby required. On the other side, in the last few years, several international studies are successfully identifying and describing specific patterns of muscle involvement, evaluated through MRI scans, in genetically different muscle disorders [<xref ref-type="bibr" rid="ref052">52–55</xref>].</p>
<p>The different forms of titinopathies show specific progression-related patterns of muscular involvement [<xref ref-type="bibr" rid="ref018">18, 19, 21, 56</xref>]. In the <italic>RYR1</italic>-related dominant central core myopathies, MRI studies show a selective involvement of vasti, sartorius and adductor magnus in the thigh and of soleus, gastrocnemii, and peroneal group in the leg with relative sparing of rectus femoris, gracilis, adductor longus and tibialis anterior [<xref ref-type="bibr" rid="ref057">57</xref>]. A similar, although more diffuse, pattern is seen in recessive <italic>RYR1</italic> myopathies [<xref ref-type="bibr" rid="ref058">58</xref>], although in the new distal calf-predominant <italic>RYR1</italic>-myopathy the target muscle was the medial gastrocnemius. A small series study has showed the characteristic involvement of the tibialis anterior and soleus and the sparing of the thigh muscles in <italic>NEB</italic>-related nemaline myopathies [<xref ref-type="bibr" rid="ref059">59</xref>].</p>
<p>As we previously suggested for recessive titinopathies [<xref ref-type="bibr" rid="ref013">13</xref>], also for other recessive diseases due to mutations in large genes, the identification of bi-allelic variants resulting into a premature stop codon (nonsense variants or small indels causing a frameshift) or the detection of previously reported mutations easily addresses the diagnosis. Novel missense and splice variants require an extensive and comprehensive characterization including in <italic>silico</italic>, <italic>in vitro</italic> and <italic>in vivo</italic> tests [<xref ref-type="bibr" rid="ref013">13, 60</xref>].</p>
<p>Missense variants can result in a diagnosis only when sufficient evidence supporting their pathogenicity is obtained [<xref ref-type="bibr" rid="ref050">50</xref>]. Many computational tools for predicting the pathogenicity of missense variants have been developed [<xref ref-type="bibr" rid="ref061">61–63</xref>]. They take into account the amino acid or nucleotide conservation or the biochemical/structural/functional properties of the amino acid change [<xref ref-type="bibr" rid="ref064">64</xref>].</p>
<p>Recently, a deep learning network for pathogenicity prediction, named PrimateAI, has been developed [<xref ref-type="bibr" rid="ref065">65</xref>]. The program has been trained using hundreds of thousands of common variants from a large population sequencing data from six non-human primate species [<xref ref-type="bibr" rid="ref065">65</xref>]. The sole analysis of the human population does not allow a correct evaluation of the frequency of a specific variant. In humans, in fact, the total number of common variants has been reduced by bottleneck events that have largely reduced the ancestral diversity. Because of these bottleneck events, only 0.1% of the missense variants have a MAF &gt; 0.1% in the human population and, consequently, most of the human missense variants are ultra-rare or private. PrimateAI evaluates the allele frequencies of a specific variant in different primate species: if a variant, affecting a conserved amino acid, is polymorphic in these species, then most probably it will be benign also in humans [<xref ref-type="bibr" rid="ref065">65</xref>].</p>
<p>Recently, Laddach and colleagues developed a web application, TITINdb, that integrates information about <italic>TTN</italic> structure, sequence, variant and disease in a single, user-friendly environment. TITINdb is a precious resource to map <italic>TTN</italic> variants to domain structures and to predict their impact using computational methods based on the protein structure and sequence [<xref ref-type="bibr" rid="ref066">66</xref>].</p>
<p>A different approach for in <italic>silico</italic> prediction is represented by ensemble methods able to combine the results of several individual predictors to improve the predictive performance [<xref ref-type="bibr" rid="ref064">64, 67</xref>]. Recently, a novel ensemble method, named REVEL, has been released [<xref ref-type="bibr" rid="ref068">68</xref>]. REVEL is reported to outperform the other existing methods for distinguishing possible disease causing missense mutations from rare missense variants with an MAF below 3% [<xref ref-type="bibr" rid="ref068">68, 69</xref>].</p>
<p>Still more complex is the interpretation of synonymous single nucleotide variants (sSNVs) that are often thought to be functionally irrelevant since they do not alter the protein sequences. However, sSNVs have been associated to hundreds of different human diseases since they can affect the transcription and the splicing regulation, the microRNA binding, the mRNA folding, and, finally, the translation [<xref ref-type="bibr" rid="ref070">70–72</xref>]. Recently, Shi and colleagues have developed IDSV (Identification of Deleterious Synonymous Variants), a computational model able to predict the possible deleterious effect of sSNVs by using a wide variety of features [<xref ref-type="bibr" rid="ref073">73</xref>].</p>
<p>Similarly, exonic variants causing missense changes as well as intronic variants may be cryptic splice mutations. Different bioinformatic tools have been developed to predict a possible splicing effect of an identified variant [<xref ref-type="bibr" rid="ref074">74, 75</xref>]. SpliceAI is a deep residual neural network that uses the genomic sequence of the pre-mRNA transcript to predict whether each position in a pre-mRNA transcript acts as a splice donor, splice acceptor, or neither and, also, to estimate the splicing effects of genetic variants in each genomic position [<xref ref-type="bibr" rid="ref076">76</xref>]. The prediction score provided by SpliceAI for each variant reflects the probability of the variant altering the splicing [<xref ref-type="bibr" rid="ref076">76</xref>]. With an accuracy over 95%, SpliceAI is reported to outperform the other available tools [<xref ref-type="bibr" rid="ref076">76</xref>].</p>
<p>In <italic>silico</italic> predictors may provide supporting evidence for pathogenicity. However, a more reliable evidence is provided by <italic>in vitro</italic> studies. Biochemical and biophysical studies, using wild-type and mutated constructs, have been used to characterize the effect of missense variants in large genes. Using thermal denaturation monitored by circular dichroism spectroscopy, Chauveau and colleagues demonstrated the reduced stability of the missense mutation within the enzymatic site of the <italic>TTN</italic> kinase domain (p.Trp34072Arg) [<xref ref-type="bibr" rid="ref077">77</xref>]. Similarly, Hastings and colleagues proved that a <italic>TTN</italic> mutation (p.Ala178Asp), located in the Z-disk region, leads to partial misfolding of bacterially expressed Z1Z2 protein fragment [<xref ref-type="bibr" rid="ref078">78</xref>].</p>
<p>A second possibility is to study the effect of a variant on protein–protein interactions. Using plasmid vectors for the expression of human nebulin super repeats, Marttila and colleagues demonstrated that a <italic>NEB</italic> missense variant (p.Ser6366Ile) causes an increased nebulin–actin affinity and a second missense variant (p.Thr7382Pro) reduces the affinity of nebulin for tropomyosin [<xref ref-type="bibr" rid="ref079">79</xref>]. Recently, an interesting nebulin super-repeat panel has been described by Laitila and colleagues [<xref ref-type="bibr" rid="ref080">80</xref>]. The panel allows the study of the actin binding of each single super-repeat and it is a precious and innovative tool to assess the effect of <italic>NEB</italic> missense changes identified in patients on nebulin-actin interaction [<xref ref-type="bibr" rid="ref080">80</xref>]. Finally, <italic>in vitro</italic> studies can provide a direct evidence of an abnormal Ca2 + homeostasis, suggesting a disease-causing effect of <italic>RYR1</italic> variants [<xref ref-type="bibr" rid="ref081">81–83</xref>].</p>
<p>Variants in canonical splice sites or predicted as being splice-disrupting also need a further cDNA validation and characterization. This is particularly important considering that large genes have multiple isoforms with a development- and tissue-specific expression [<xref ref-type="bibr" rid="ref043">43–45, 47</xref>]. Splice variants can result in an out-of-frame deletion or insertion and, consequently, in a premature truncation; however, they can also result in a slightly longer or smaller protein (as a consequence of an in-frame deletion or insertion, in particular in presence of symmetric exons). A further characterization of the protein expression and function is strongly recommended for a proper evaluation of the mis-splicing effect.</p>
<p>A good example of the aforementioned issues with interpretation of splicing variants is represented by the recently identified recurrent <italic>TTN</italic> intronic splice-site variant (c.39974-11T&gt;G) [<xref ref-type="bibr" rid="ref084">84</xref>]. A large segregation in eight families where the variant, in <italic>trans</italic> with a second causative variant, co-segregated with the disease and a comprehensive analysis of expression data strongly suggested the pathogenic role of the identified variant [<xref ref-type="bibr" rid="ref084">84</xref>].</p>
<p>A more robust proof of pathogenicity can be provided with functional genomics studies. Functional genomics approaches include a number tools, requiring for example patients' cells, micro-organism or animal models, that can be used (often in combinations among them or with <italic>in vitro</italic> studies) to obtain additional evidence for pathogenicity of genetic variants [<xref ref-type="bibr" rid="ref085">85</xref>].</p>
<p>The availability of protocols to reprogram somatic cells into pluripotent stem cells (iPSCs) enables, for example, the study of sarcomere organization in iPSC myocytes and cardiomyocytes derived from patients' fibroblasts [<xref ref-type="bibr" rid="ref086">86, 87</xref>]. On the other hand, RNA-guided CRISPR (clustered regularly interspaced short palindromic repeat)-associated Cas proteins can be utilized to create knock in cellular and, above all, animal models and mimic patients', and hopefully disease, states [<xref ref-type="bibr" rid="ref088">88, 89</xref>].</p>
<p>So far, animal models have been mainly used to prove that a novel gene, previously not reported as disease causing, is implicated in the observed disease (gene discovery) and/or to provide information on the pathophysiological mechanisms triggered by the gene mutations [<xref ref-type="bibr" rid="ref090">90, 91</xref>].</p>
<p>For pathophysiology studies and for testing potential therapeutic strategies, zebrafish models of nemaline myopathy, titinopathy and Ryr1-related myopathies have been used [<xref ref-type="bibr" rid="ref092">92–94</xref>].</p>
<p>Similarly, to study the physiopathology of the dominant tibial muscular dystrophy (TMD) and the recessive limb-girdle muscular dystrophy (LGMD2J or LGMD R10 titin-related) due to heterozygosity and homozygosity for the FINmaj mutation, Charton and colleagues generated a mouse model carrying the same mutation [<xref ref-type="bibr" rid="ref095">95</xref>]. Several <italic>RYR1</italic> knock in mouse models have been generated to mimic the equivalent mutations identified in humans [<xref ref-type="bibr" rid="ref096">96–99</xref>]. Recently, Laitila and colleagues have generated and characterized a mouse model with compound heterozygous Neb mutations (a missense p.Tyr2303His and a nonsense p.Tyr935*), matching the genotype observed in patients with a nemaline myopathy [<xref ref-type="bibr" rid="ref100">100, 101</xref>].</p>
<p>An interesting perspective is represented by the recently developed Gene Replacement (GR) technology that enables to replace mouse genes with their full human orthologs [<xref ref-type="bibr" rid="ref102">102</xref>]. The new full gene-replacement model would mimic the same expression, regulation and function of the human gene, improving our understanding of the gene function, of the disease mechanisms triggered by gene mutations and, finally, providing a valuable model for possible treatment options [<xref ref-type="bibr" rid="ref102">102</xref>]. The feasibility of this approach for large genes is still to be proven.</p>
<p>Finally, considering the sheer size of these genes and their complex structure with repetitive areas and GC-rich regions, sequencing parameters (e.g. depth and coverage) need to be carefully evaluated for a proper interpretation of the genetic results [<xref ref-type="bibr" rid="ref011">11</xref>]. The sole DNA sequencing, in particular a non-custom tailored exome sequencing, and the traditional algorithms in use in a diagnostic setting (mainly aiming at the detection of SNV or small indels) can still result into a number of elusive damaging variants. As discussed below, a more exhaustive workflow, including further bioinformatic analyses and second-tier tests, often results in a higher diagnostic rate, revealing variants missed by the traditional diagnostic methods.</p>
</sec>
<sec id="sec0035">
<title>THE IDENTIFICATION OF COPY NUMBER VARIANTS FROM HTS DATA</title>
<p>Copy number variants are genomic regions of loss or gain of at least 50 bp in size, which are formed by distinct mechanisms compared to SNVs and indels [<xref ref-type="bibr" rid="ref103">103</xref>]. CNVs are estimated to cause approximately 10% of disorders, and they seem to be even more involved in neurological disorders than in many other disorder groups [<xref ref-type="bibr" rid="ref104">104, 105</xref>]. CNVs can be detected from various types of next generation sequencing (NGS) data, and numerous CNV detection algorithms have been developed during recent years [<xref ref-type="bibr" rid="ref103">103, 106</xref>]. Usually, different technical approaches are needed for WES and gene panel data compared to WGS data, since the former produce non-continuous sequencing data [<xref ref-type="bibr" rid="ref107">107</xref>]. The CNV detection algorithms designed for WES and gene panel data require high average read-depth and uniform coverage to provide sensitive and reliable CNV detection results, which puts restrictions on the quality of NGS data [<xref ref-type="bibr" rid="ref108">108</xref>]. Additionally, the whole spectrum of genomic structural variation can be detected only from WGS data, as opposed to deletions and duplication, which are detectable also from targeted sequencing data [<xref ref-type="bibr" rid="ref107">107</xref>].</p>
<p>The CNV detection algorithms tend to have differing CNV detection accuracy and biases in detected CNV classes: therefore, utilizing more than one algorithm is generally recommended to achieve comprehensive CNV detection results [<xref ref-type="bibr" rid="ref106">106, 109–111</xref>]. Kosugi and colleagues list CNV detection algorithms for WGS data with relatively best performances for each structural variation category, including CNVs [<xref ref-type="bibr" rid="ref103">103</xref>]. For now, studies with comparably comprehensive algorithm comparisons are not available for WES and gene panel sequencing data, but numerous studies of smaller scale have been published to aid in making the choice [<xref ref-type="bibr" rid="ref105">105, 106, 109, 110</xref>].</p>
<p>Large deletions or duplications in the DMD gene are a well-known cause of Duchenne and Becker muscular dystrophies (70–80% of cases) and multiplex ligation-dependent probe amplification (MLPA) is the current standard for clinical CNV analysis in DMD [<xref ref-type="bibr" rid="ref112">112, 113</xref>]. Two hot spots, proximal with exons 2–20 and distal with exons 45–55, contain most of the CNV. Nevertheless, the detected CNVs are highly heterogeneous. The breakpoints land mostly in the very large introns. For most of the DMD and BMD patients (&gt;90%), the phenotype severity depends on the effect of the CNV on translation, premature termination of protein synthesis through deleterious change in read-frame being the most notable [<xref ref-type="bibr" rid="ref112">112</xref>]. Therefore, detecting CNVs precisely on exon level is highly important in the case of dystrophinopathies. This is quite feasible from NGS data, with separate approaches developed specifically for analyzing CNVs in the gene DMD due to its high clinical significance, but more general approaches have provided detections as well [<xref ref-type="bibr" rid="ref114">114, 115</xref>].</p>
<p>The large size of certain genes involved in neuromuscular disorders in itself does not pose a problem for CNV analysis from NGS data. However, nebulin and titin provide unique challenges for CNV detection due to regions of segmental duplications [<xref ref-type="bibr" rid="ref016">16, 23, 116</xref>]. Repetitive gene sequences are challenging to sequence and align accurately, which leads to imprecise basis for accurate CNV analysis on these regions [<xref ref-type="bibr" rid="ref107">107</xref>]. These regions are especially difficult to decipher from non-continuous short-read sequencing data from WES and gene panels. For unambiguous sequencing and mapping of these repeated regions, special approaches are probably needed, namely specific probe designs and/or long-read sequencing, even with WGS approaches [<xref ref-type="bibr" rid="ref011">11</xref>]. These regions could be actually of special interest: changes in the number of triplicate region blocks in the gene <italic>NEB</italic> are potentially pathogenic [<xref ref-type="bibr" rid="ref116">116</xref>]. CNVs from other regions of these giant genes have been detected during recent years, also with NGS approaches. In <italic>TTN</italic>, CNVs have been detected to cause myopathies with or without cardiac involvement in compound heterozygosity with other variant types [<xref ref-type="bibr" rid="ref029">29, 115, 117</xref>] and in <italic>NEB</italic> with even more variable outcomes [<xref ref-type="bibr" rid="ref024">24, 30, 115</xref>]. Recently, a large heterozygous deletion in <italic>NEB</italic> was identified as being the cause of a distal myopathy through a probable dominant negative mechanism on molecular level [<xref ref-type="bibr" rid="ref030">30</xref>]. This is the first reported dominant disease for <italic>NEB</italic>, suggesting that different rules may apply for CNVs than for other types of variants in consideration of their clinical significance and effects. Generally, CNVs as disease causing discoveries seem to be rare for these genes, maybe due to difficulties in analyzing the genes with old methods.</p>
<p>CNVs have been discovered also in some other genes causing a skeletal muscle disorder, such as <italic>LAMA2</italic>, <italic>MTM1</italic> [<xref ref-type="bibr" rid="ref119">119</xref>], <italic>RYR1</italic> [<xref ref-type="bibr" rid="ref120">120</xref>], <italic>SACS</italic> [<xref ref-type="bibr" rid="ref121">121</xref>], <italic>SGCB</italic> [<xref ref-type="bibr" rid="ref122">122</xref>] and others [<xref ref-type="bibr" rid="ref123">123</xref>]. Nevertheless, it is probable that large genes with few verified CNVs detected by any methods so far (e.g. <italic>PLEC</italic> or <italic>LARGE</italic>) will have ones soon, with the amount of comprehensive genetic variation studies increasing.</p>
<p>Following detection of potentially interesting CNVs, inferring their clinical significance and effects is even less straightforward than for SNVs or small indels: the variant databases available for CNVs are generally not as well curated as for other variant types [<xref ref-type="bibr" rid="ref124">124</xref>]. Additionally, comparing CNVs to ones in these databases is not unequivocal, since the reported breakpoints of the CNVs could differ depending on their original detection methods [<xref ref-type="bibr" rid="ref124">124, 125</xref>]. The American College of Medical Genetics (ACMG) has published very recently guidelines for interpreting and reporting germline CNVs [<xref ref-type="bibr" rid="ref126">126</xref>]. The application of these guidelines will probably modify the interpretation of CNVs in a diagnostic setting. The CNV guidelines will be probably improved and customized for a more efficient diagnostic use. In the meanwhile, the CNV detection results still need to be regarded with caution and may need to be verified with complementary methods [<xref ref-type="bibr" rid="ref105">105, 111, 123</xref>]. This increases workload and costs, thus setting back use of NGS methods as an independent first-tier diagnostic test.</p>
</sec>
<sec id="sec0040">
<title>RNA sequencing as Second Tier Test</title>
<p>RNA sequencing (RNAseq) is a convenient second tier test that complements a DNA-based method and is able to identify possible elusive variants [<xref ref-type="bibr" rid="ref127">127, 128</xref>]. The low detection rate of DNA tests is probably due to several reasons. Complex genetic mechanisms, such as a digenic or oligogenic inheritance, and the presence of causative mosaic variants, can probably explain the observed phenotype in part of the unsolved cases [<xref ref-type="bibr" rid="ref129">129–132</xref>]. On the other hand, part of the patients with an undiagnosed disease carry variants that are not detectable (for example deep intronic variants in exome sequencing) or variants not correctly interpreted (e.g. synonymous variants) [<xref ref-type="bibr" rid="ref010">10</xref>].</p>
<p>Cryptic splice mutations explain 9–11% of cases with intellectual disability or autism spectrum disorders, respectively [<xref ref-type="bibr" rid="ref076">76</xref>]. A correct evaluation of elusive splice variants, using bioinformatic tools and RNASeq, can result into a similar increase in the diagnostic yield in most of the other rare genetic diseases. Similarly, the integration of RNAseq with genome sequencing has resulted in an improved diagnostic rate for a wide spectrum of undiagnosed Mendelian diseases [<xref ref-type="bibr" rid="ref133">133</xref>]. Moreover, the availability of the most appropriate tissue for RNA extraction/analysis further increases the diagnostic rate [<xref ref-type="bibr" rid="ref018">18, 128</xref>]. For skeletal muscle disorders, muscle is the most informative tissue due to the higher expression of disease genes [<xref ref-type="bibr" rid="ref128">128</xref>].</p>
<p>After the first report of a novel re-occurring <italic>COL6A2</italic> mutation (c.930 + 189C &gt;  T) identified using a well-designed workflow for prioritizing candidate aberrant splicing events [<xref ref-type="bibr" rid="ref127">127</xref>], a similar approach has been successfully used to screen unsolved patients with a nemaline myopathy [<xref ref-type="bibr" rid="ref134">134</xref>]. Hamanaka and colleagues identified a novel deep-intronic <italic>NEB</italic> pathogenic variant (c.1569 + 339A &gt;  G) and a synonymous <italic>NEB</italic> pathogenic variant (c.24684G &gt;  C; p.Ser8228Ser affecting the last nucleotide of exon 175), both resulting in an aberrant splicing [<xref ref-type="bibr" rid="ref134">134</xref>].</p>
<p>A different approach, described by Lee and colleagues, is of the extreme interest [<xref ref-type="bibr" rid="ref133">133</xref>]. Instead of analyzing the entire transcriptome to search for an outlier (as described in ref. [<xref ref-type="bibr" rid="ref127">127, 134</xref>]), they used RNAseq to evaluate the effect on the transcripts of rare, potentially causative, genetic variants using the splicing predictors as a prioritizing method [<xref ref-type="bibr" rid="ref133">133</xref>].</p>
<p>A muscle biopsy is routinely collected during the diagnostic procedure for patients with skeletal muscle disorders. However, the use of transcriptome analysis for a diagnostic purpose will benefit from the development of methods to transdifferentiate <italic>ex vivo</italic> skin fibroblasts or blood mononuclear cells, not requiring invasive medical procedures, to specific cell types. This will virtually enable the analysis of transcripts with a development-specific expression.</p>
<p>It is noteworthy that the interpretation of RNAseq data is still challenging because of the presence of natural splice variants that need to be distinguished from the pathogenic splicing defects. Improved algorithms and defined guidelines will probably facilitate the interpretation of these data.</p>
<p>Finally, the effect of splice defects on translation needs to be carefully evaluated.</p>
</sec>
<sec id="sec0045">
<title>Final Considerations and Future Perspectives</title>
<p>The introduction of HTS has allowed us to overcome the technical difficulties related to the size of the gene. DNA and RNAsequencing and, above all, their combined use enable an exhaustive analysis of most of the human genes and their size is not an issue anymore [<xref ref-type="bibr" rid="ref133">133</xref>].</p>
<p>The use of long-reads and linked-reads sequencing technologies will probably result into several technical improvements, allowing the detection of complex structural variations, large segmental duplications and possible microsatellite expansions, such as trinucleotide repeat expansion [<xref ref-type="bibr" rid="ref135">135–137</xref>]. These technologies will also improve the variant detection in repetitive regions where short reads do not map uniquely. Finally, an important (and often neglected) aspect is related to the phase information [<xref ref-type="bibr" rid="ref138">138</xref>]. Short reads collapse the diploid genome in a single sequence. Phasing variants using segregation studies is sometimes time-consuming and, somehow, not cost-effective. These new technologies provide phase information over long contiguous DNA segments [<xref ref-type="bibr" rid="ref138">138</xref>]. Large genes will probably benefit the most from the introduction of long-reads and linked-reads sequencing technologies.</p>
<p>The most challenging aspect for the diagnosis of skeletal muscle disorders is definitively related to the clinical interpretation of the high number of rare variants detected in large genes (<xref ref-type="table" rid="jnd-7-jnd190459-t002">Table 2</xref>). Despite the possible improvements in the variant interpretation and the definition of gene-tailored guidelines, the variant interpretation is a dynamic process. It evolves because of multiple factors including a better understanding of the disease, the availability of more performant in <italic>silico</italic> predictors and of additional population data, the development of novel <italic>in vitro</italic> and <italic>in vivo</italic> functional studies and the identification of novel cases [<xref ref-type="bibr" rid="ref139">139–141</xref>]. Previous studies have questioned, for example, the pathogenicity of mutations associated with the limb girdle muscular dystrophies (LGMDs) or with a cardiomyopathy, suggesting the need for a periodic, careful re-evaluation of the experimental findings [<xref ref-type="bibr" rid="ref139">139, 140</xref>]. A recent study by Appelbaum and colleagues has discussed the ethical duty to reinterpret experimentally identified variants, concluding that we all need to re-evaluate periodically our findings in the light of technical and interpretative improvements[<xref ref-type="bibr" rid="ref142">142</xref>].</p>
<table-wrap id="jnd-7-jnd190459-t002" orientation="portrait" position="float">
<label>Table 2</label>
<caption>
<p>Challenges and possible improvements in variant interpretation</p>
</caption>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1"/>
<col align="justify" span="1"/>
</colgroup>
<thead valign="top">
<tr>
<td colspan="1" rowspan="1">Key points for variant interpretation</td>
<td colspan="1" rowspan="1">Challenges</td>
<td colspan="1" rowspan="1">Possible improvements</td>
</tr>
</thead>
<tbody>
<tr>
<td colspan="1" rowspan="1">Deep phenotyping</td>
<td colspan="1" rowspan="1">Identification of clinical gene-related hallmarks</td>
<td colspan="1" rowspan="1">International natural history studies on large cohorts of patients; a large consensus on the diagnostic and prognostic value of each test/hallmark</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Population data: allele frequency threshold</td>
<td colspan="1" rowspan="1">Phenotypic divergence (1 gene = several diseases)</td>
<td colspan="1" rowspan="1">Large epidemiological studies</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Phasing/segregation</td>
<td colspan="1" rowspan="1">Time-consuming and cost-ineffective PCR-based analysis</td>
<td colspan="1" rowspan="1">Novel sequencing technologies, TRIO or multi-sample sequencing</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Elusive variants</td>
<td colspan="1" rowspan="1">Repetitive regions, low covered areas, CNV-prone sequences, cryptic splice-causing variants</td>
<td colspan="1" rowspan="1">Improved computational tools, novel sequencing technologies, second-tier tests</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Variant annotation/functional validation:</td>
</tr>
<tr>
<td colspan="1" rowspan="1">  In <italic>silico</italic> tools</td>
<td colspan="1" rowspan="1">Conflicting predictions; uncertain accuracy</td>
<td colspan="1" rowspan="1">Improved (more accurate) computational tools</td>
</tr>
<tr>
<td colspan="1" rowspan="1">  <italic>In vitro</italic> experiments</td>
<td colspan="1" rowspan="1">Large proteins to be dissected in more manageable fragments</td>
<td colspan="1" rowspan="1">Benchmark assays</td>
</tr>
<tr>
<td colspan="1" rowspan="1">  <italic>In vivo</italic> or <italic>ex vivo</italic> experiments</td>
<td colspan="1" rowspan="1">High cost, non-scalability</td>
<td colspan="1" rowspan="1">International multidisciplinary consortia</td>
</tr>
<tr>
<td colspan="1" rowspan="1">  Public disease-databases</td>
<td colspan="1" rowspan="1">Not standardized interpretation; limited number of shared variants</td>
<td colspan="1" rowspan="1">Sharing data; gene/disease-tailored guidelines for an improved variant interpretation</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>A crucial aspect for a proper evaluation of the sequence variants is represented by the choice of appropriate functional studies. Although recommendations have been recently issued to provide a detailed guidance on the evaluation of functional data [<xref ref-type="bibr" rid="ref143">143, 144</xref>], for the large genes discussed here, we do not have a general agreement on the assays providing sufficient evidence. Moreover, the large size of the coding region is a considerable issue for specific applications (e.g. cloning full-length sequence or – mainly for titin - protein expression study). It is however noteworthy that, in the context of MYH7-associated inherited cardiomyopathies, a panel of experts suggested that only functional data from mammalian knock-in models provide supporting evidence of the variant damaging effect [<xref ref-type="bibr" rid="ref145">145</xref>].</p>
<p>As discussed by Dr Rodenburg in his recent review [<xref ref-type="bibr" rid="ref085">85</xref>], obtaining functional evidence of pathogenicity requires huge work and money. This effort brings a reward in terms of scientific impact (and of granted funds) when the novel variants are in novel disease genes. The same effort is much less rewarding in a diagnostic setting when the variants are in very well-known disease-genes. However, a correct diagnosis is important for patients and an international collaborative effort aiming at setting up and validating functional assays for the genes discussed here is strongly advisable.</p>
<p>Finally, HTS has contributed to the identification of digenic, or even more complex, genetic mechanisms underlying human diseases [<xref ref-type="bibr" rid="ref129">129, 132, 146</xref>]. This should be considered when evaluating the functional and clinical impact of variants of unknown significance.</p>
<p>Our understanding of large genes will benefit from large, international and interdisciplinary consortia [<xref ref-type="bibr" rid="ref147">147–150</xref>]. A larger cohort of patients, shared clinical and genetic data and shared scientific and technological resources are needed for these complex challenges [<xref ref-type="bibr" rid="ref148">148–150</xref>]. Similarly, making available experimentally identified variants and the interpretation of their clinical significance through public databases will help to standardize the assessment of variant pathogenicity among different laboratories [<xref ref-type="bibr" rid="ref151">151–153</xref>].</p>
<p>A perfect synergy among scientists and clinicians with a multidisciplinary expertise are required to set up a full translational research, going from variant identification in patients to characterization of pathophysiological mechanisms in muscular cells and animal models, from basic research to clinical developments - all for the benefit of the patients [<xref ref-type="bibr" rid="ref148">148, 150</xref>].</p>
</sec>
<sec id="sec0050" sec-type="COI-statement">
<title>CONFLICT OF INTEREST</title>
<p>The authors have no conflict of interest to report.</p>
</sec>
</body>
<back>
<ack>
<title>ACKNOWLEDGMENTS</title>
<p>This study was supported by Association Francaise contre les Myopathies (M.S.), Orion foundation (M.S.), Magnus Ehrnrooth Foundation (M.S.), Päivikki ja Sakari Sohlbergin Säätiö (M.S.and M.J.), Biomedicum Helsinki säätiö (M.J.), Jane and Aatos Erkko Foundation (P.H.), Medicinska Understödsföreningen Liv och Hälsa rf (P.H.), Folkhälsan Research Foundation (B.U.), Erkko Foundation (B.U.), Juselius Foundation (B.U.), Finnish Academy (B.U.), Alfred Kordelin Foundation (S.V.).</p>
</ack>
<ref-list>
<title>REFERENCES</title>
<ref id="ref001">
<label>[1]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Lander</surname>
<given-names>ES</given-names>
</string-name>, <string-name>
<surname>Linton</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Birren</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Nusbaum</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Zody</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Baldwin</surname>
<given-names>J</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Initial sequencing and analysis of the human genome</article-title>. <source/>Nature. <year>2001</year>;<volume>409</volume>(<issue>6822</issue>):<fpage>860</fpage>–<lpage>921</lpage>.<pub-id pub-id-type="pmid">11237011</pub-id></mixed-citation>
</ref>
<ref id="ref002">
<label>[2]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Lynch</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Conery</surname>
<given-names>JS</given-names>
</string-name>. <article-title>The origins of genome complexity</article-title>. <source/>Science. <year>2003</year>;<volume>302</volume>(<issue>5649</issue>):<fpage>1401</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="pmid">14631042</pub-id></mixed-citation>
</ref>
<ref id="ref003">
<label>[3]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Koenig</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hoffman</surname>
<given-names>EP</given-names>
</string-name>, <string-name>
<surname>Bertelson</surname>
<given-names>CJ</given-names>
</string-name>, <string-name>
<surname>Monaco</surname>
<given-names>AP</given-names>
</string-name>, <string-name>
<surname>Feener</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Kunkel</surname>
<given-names>LM</given-names>
</string-name>. <article-title>Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals</article-title>. <source/>Cell. <year>1987</year>;<volume>50</volume>(<issue>3</issue>):<fpage>509</fpage>–<lpage>17</lpage>.<pub-id pub-id-type="pmid">3607877</pub-id></mixed-citation>
</ref>
<ref id="ref004">
<label>[4]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Sahakyan</surname>
<given-names>AB</given-names>
</string-name>, <string-name>
<surname>Balasubramanian</surname>
<given-names>S</given-names>
</string-name>. <article-title>Long genes and genes with multiple splice variants are enriched in pathways linked to cancer and other multigenic diseases</article-title>. <source/>BMC Genomics. <year>2016</year>;<volume>17</volume>:<fpage>225</fpage>.<pub-id pub-id-type="pmid">26968808</pub-id></mixed-citation>
</ref>
<ref id="ref005">
<label>[5]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Grishkevich</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Yanai</surname>
<given-names>I</given-names>
</string-name>. <article-title>Gene length and expression level shape genomic novelties</article-title>. <source/>Genome Res. <year>2014</year>;<volume>24</volume>(<issue>9</issue>):<fpage>1497</fpage>–<lpage>503</lpage>.<pub-id pub-id-type="pmid">25015383</pub-id></mixed-citation>
</ref>
<ref id="ref006">
<label>[6]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Higgins</surname>
<given-names>DG</given-names>
</string-name>, <string-name>
<surname>Labeit</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Gautel</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Gibson</surname>
<given-names>TJ</given-names>
</string-name>. <article-title>The evolution of titin and related giant muscle proteins</article-title>. <source/>J Mol Evol. <year>1994</year>;<volume>38</volume>(<issue>4</issue>):<fpage>395</fpage>–<lpage>404</lpage>.<pub-id pub-id-type="pmid">8007007</pub-id></mixed-citation>
</ref>
<ref id="ref007">
<label>[7]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Clark</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Stark</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Farnaes</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>TY</given-names>
</string-name>, <string-name>
<surname>White</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Dimmock</surname>
<given-names>D</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases</article-title>. <source/>NPJ Genom Med. <year>2018</year>;<volume>3</volume>:<fpage>16</fpage>.<pub-id pub-id-type="pmid">30002876</pub-id></mixed-citation>
</ref>
<ref id="ref008">
<label>[8]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Metzker</surname>
<given-names>ML</given-names>
</string-name>. <article-title>Sequencing technologies - the next generation</article-title>. <source/>Nat Rev Genet. <year>2010</year>;<volume>11</volume>(<issue>1</issue>):<fpage>31</fpage>–<lpage>46</lpage>.<pub-id pub-id-type="pmid">19997069</pub-id></mixed-citation>
</ref>
<ref id="ref009">
<label>[9]</label>
<mixed-citation publication-type="other">
<string-name>
<surname>Gutowska-Ding</surname>
<given-names>MW</given-names>
</string-name>, <string-name>
<surname>Deans</surname>
<given-names>ZC</given-names>
</string-name>, <string-name>
<surname>Roos</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Matilainen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Khawaja</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Brugger</surname>
<given-names>K</given-names>
</string-name>, <etal>et al.</etal> One byte at a time: evidencing the quality of clinical service next-generation sequencing for germline and somatic variants. Eur J Hum Genet. 2019.</mixed-citation>
</ref>
<ref id="ref010">
<label>[10]</label>
<mixed-citation publication-type="other">
<string-name>
<surname>Nigro</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Savarese</surname>
<given-names>M</given-names>
</string-name>. Next-generation sequencing approaches for the diagnosis of skeletal muscle disorders. Curr Opin Neurol. 2016;29(5):621–7.</mixed-citation>
</ref>
<ref id="ref011">
<label>[11]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Zenagui</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Lacourt</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Pegeot</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Yauy</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Juntas Morales</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Theze</surname>
<given-names>C</given-names>
</string-name>, <etal>et al.</etal>
<article-title>A reliable targeted next-generation sequencing strategy for diagnosis of myopathies and muscular dystrophies. Especially for the Giant Titin and Nebulin Genes</article-title>. <source/>J Mol Diagn. <year>2018</year>;<volume>20</volume>(<issue>4</issue>):<fpage>533</fpage>–<lpage>49</lpage>.<pub-id pub-id-type="pmid">29792937</pub-id></mixed-citation>
</ref>
<ref id="ref012">
<label>[12]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Abdalla</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Ravenscroft</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Zayed</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Beecroft</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Laing</surname>
<given-names>NG</given-names>
</string-name>. <article-title>Lethal multiple pterygium syndrome: A severe phenotype associated with a novel mutation in the nebulin gene</article-title>. <source/>Neuromuscul Disord. <year>2017</year>;<volume>27</volume>(<issue>6</issue>):<fpage>537</fpage>–<lpage>41</lpage>.<pub-id pub-id-type="pmid">28336317</pub-id></mixed-citation>
</ref>
<ref id="ref013">
<label>[13]</label>
<mixed-citation publication-type="other">
<string-name>
<surname>Savarese</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Maggi</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Vihola</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Jonson</surname>
<given-names>PH</given-names>
</string-name>, <string-name>
<surname>Tasca</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Ruggiero</surname>
<given-names>L</given-names>
</string-name>, <etal>et al.</etal> Interpreting genetic variants in titin in patients with muscle disorders. JAMA Neurol. 2018;75(5):557–65.</mixed-citation>
</ref>
<ref id="ref014">
<label>[14]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Jokela</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tasca</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Vihola</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Mercuri</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Jonson</surname>
<given-names>PH</given-names>
</string-name>, <string-name>
<surname>Lehtinen</surname>
<given-names>S</given-names>
</string-name>, <etal>et al.</etal>
<article-title>An unusual ryanodine receptor 1 (RYR1) phenotype: Mild calf-predominant myopathy</article-title>. <source/>Neurology. <year>2019</year>;<volume>92</volume>(<issue>14</issue>):<fpage>e1600</fpage>–<lpage>e9</lpage>.<pub-id pub-id-type="pmid">30842289</pub-id></mixed-citation>
</ref>
<ref id="ref015">
<label>[15]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Bonne</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Rivier</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Hamroun</surname>
<given-names>D</given-names>
</string-name>. <article-title>The version of the gene table of neuromuscular disorders (nuclear genome)</article-title>. <source/>Neuromuscul Disord. <year>2018</year>;<volume>28</volume>(<issue>12</issue>):<fpage>1031</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="pmid">30472062</pub-id></mixed-citation>
</ref>
<ref id="ref016">
<label>[16]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Bang</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Centner</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Fornoff</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Geach</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Gotthardt</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>McNabb</surname>
<given-names>M</given-names>
</string-name>, <etal>et al.</etal>
<article-title>The complete gene sequence of titin, expression of an unusual approximately 700-kDa titin isoform, and its interaction with obscurin identify a novel Z-line to I-band linking system</article-title>. <source/>Circ Res. <year>2001</year>;<volume>89</volume>(<issue>11</issue>):<fpage>1065</fpage>–<lpage>72</lpage>.<pub-id pub-id-type="pmid">11717165</pub-id></mixed-citation>
</ref>
<ref id="ref017">
<label>[17]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Savarese</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sarparanta</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Vihola</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Udd</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Hackman</surname>
<given-names>P</given-names>
</string-name>. <article-title>Increasing role of titin mutations in neuromuscular disorders</article-title>. <source/>Journal of Neuromuscular Diseases. <year>2016</year>;<volume>3</volume>(<issue>3</issue>):<fpage>293</fpage>–<lpage>308</lpage>.<pub-id pub-id-type="pmid">27854229</pub-id></mixed-citation>
</ref>
<ref id="ref018">
<label>[18]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Evila</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Palmio</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Vihola</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Savarese</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tasca</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Penttila</surname>
<given-names>S</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Targeted next-generation sequencing reveals novel TTN mutations causing recessive distal titinopathy</article-title>. <source/>Mol Neurobiol. <year>2017</year>;<volume>54</volume>(<issue>9</issue>):<fpage>7212</fpage>–<lpage>23</lpage>.<pub-id pub-id-type="pmid">27796757</pub-id></mixed-citation>
</ref>
<ref id="ref019">
<label>[19]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Oates</surname>
<given-names>EC</given-names>
</string-name>, <string-name>
<surname>Jones</surname>
<given-names>KJ</given-names>
</string-name>, <string-name>
<surname>Donkervoort</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Charlton</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Brammah</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Smith</surname>
<given-names>JE</given-names>
<suffix>3rd</suffix>
</string-name>, <etal>et al.</etal>
<article-title>Congenital titinopathy: Comprehensive characterization and pathogenic insights</article-title>. <source/>Ann Neurol. <year>2018</year>;<volume>83</volume>(<issue>6</issue>):<fpage>1105</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="pmid">29691892</pub-id></mixed-citation>
</ref>
<ref id="ref020">
<label>[20]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Hackman</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Vihola</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Haravuori</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Marchand</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sarparanta</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>De Seze</surname>
<given-names>J</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin</article-title>. <source/>Am J Hum Genet. <year>2002</year>;<volume>71</volume>(<issue>3</issue>):<fpage>492</fpage>–<lpage>500</lpage>.<pub-id pub-id-type="pmid">12145747</pub-id></mixed-citation>
</ref>
<ref id="ref021">
<label>[21]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Palmio</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Leonard-Louis</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sacconi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Savarese</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Penttila</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Semmler</surname>
<given-names>AL</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Expanding the importance of HMERF titinopathy: New mutations and clinical aspects</article-title>. <source/>J Neurol. <year>2019</year>;<volume>266</volume>(<issue>3</issue>):<fpage>680</fpage>–<lpage>90</lpage>.<pub-id pub-id-type="pmid">30666435</pub-id></mixed-citation>
</ref>
<ref id="ref022">
<label>[22]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Tasca</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Udd</surname>
<given-names>B</given-names>
</string-name>. <article-title>Hereditary myopathy with early respiratory failure (HMERF): Still rare, but common enough</article-title>. <source/>Neuromuscul Disord. <year>2018</year>;<volume>28</volume>(<issue>3</issue>):<fpage>268</fpage>–<lpage>76</lpage>.<pub-id pub-id-type="pmid">29361395</pub-id></mixed-citation>
</ref>
<ref id="ref023">
<label>[23]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Bang</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Caremani</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Brunello</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Littlefield</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Lieber</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>J</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Nebulin plays a direct role in promoting strong actin-myosin interactions</article-title>. <source/>FASEB journal: Official publication of the Federation of American Societies for Experimental Biology. <year>2009</year>;<volume>23</volume>(<issue>12</issue>):<fpage>4117</fpage>–<lpage>25</lpage>.<pub-id pub-id-type="pmid">19679637</pub-id></mixed-citation>
</ref>
<ref id="ref024">
<label>[24]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Lehtokari</surname>
<given-names>VL</given-names>
</string-name>, <string-name>
<surname>Kiiski</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Sandaradura</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Laporte</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Repo</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Frey</surname>
<given-names>JA</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Mutation update: the spectra of nebulin variants and associated myopathies</article-title>. <source/>Hum Mutat. <year>2014</year>;<volume>35</volume>(<issue>12</issue>):<fpage>1418</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="pmid">25205138</pub-id></mixed-citation>
</ref>
<ref id="ref025">
<label>[25]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Lehtokari</surname>
<given-names>VL</given-names>
</string-name>, <string-name>
<surname>Pelin</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Herczegfalvi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Karcagi</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Pouget</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Franques</surname>
<given-names>J</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Nemaline myopathy caused by mutations in the nebulin gene may present as a distal myopathy</article-title>. <source/>Neuromuscul Disord. <year>2011</year>;<volume>21</volume>(<issue>8</issue>):<fpage>556</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="pmid">21724397</pub-id></mixed-citation>
</ref>
<ref id="ref026">
<label>[26]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Wallgren-Pettersson</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Lehtokari</surname>
<given-names>VL</given-names>
</string-name>, <string-name>
<surname>Kalimo</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Paetau</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Nuutinen</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Hackman</surname>
<given-names>P</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Distal myopathy caused by homozygous missense mutations in the nebulin gene</article-title>. <source/>Brain. <year>2007</year>;<volume>130</volume>(<issue>Pt 6</issue>):<fpage>1465</fpage>–<lpage>76</lpage>.<pub-id pub-id-type="pmid">17525139</pub-id></mixed-citation>
</ref>
<ref id="ref027">
<label>[27]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Romero</surname>
<given-names>NB</given-names>
</string-name>, <string-name>
<surname>Lehtokari</surname>
<given-names>VL</given-names>
</string-name>, <string-name>
<surname>Quijano-Roy</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Monnier</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Claeys</surname>
<given-names>KG</given-names>
</string-name>, <string-name>
<surname>Carlier</surname>
<given-names>RY</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Core-rod myopathy caused by mutations in the nebulin gene</article-title>. <source/>Neurology. <year>2009</year>;<volume>73</volume>(<issue>14</issue>):<fpage>1159</fpage>–<lpage>61</lpage>.<pub-id pub-id-type="pmid">19805734</pub-id></mixed-citation>
</ref>
<ref id="ref028">
<label>[28]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Feingold-Zadok</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Chitayat</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Chong</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Injeyan</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Shannon</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Chapmann</surname>
<given-names>D</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Mutations in the NEB gene cause fetal akinesia/arthrogryposis multiplex congenita</article-title>. <source/>Prenat Diagn. <year>2017</year>;<volume>37</volume>(<issue>2</issue>):<fpage>144</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="pmid">27933661</pub-id></mixed-citation>
</ref>
<ref id="ref029">
<label>[29]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Sagath</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Lehtokari</surname>
<given-names>VL</given-names>
</string-name>, <string-name>
<surname>Valipakka</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Udd</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Wallgren-Pettersson</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Pelin</surname>
<given-names>K</given-names>
</string-name>, <etal>et al.</etal>
<article-title>An extended targeted copy number variation detection array including 187 genes for the diagnostics of neuromuscular disorders</article-title>. <source/>J Neuromuscul Dis. <year>2018</year>;<volume>5</volume>(<issue>3</issue>):<fpage>307</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="pmid">30040739</pub-id></mixed-citation>
</ref>
<ref id="ref030">
<label>[30]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Kiiski</surname>
<given-names>KJ</given-names>
</string-name>, <string-name>
<surname>Lehtokari</surname>
<given-names>VL</given-names>
</string-name>, <string-name>
<surname>Vihola</surname>
<given-names>AK</given-names>
</string-name>, <string-name>
<surname>Laitila</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Huovinen</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sagath</surname>
<given-names>LJ</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Dominantly inherited distal nemaline/cap myopathy caused by a large deletion in the nebulin gene</article-title>. <source/>Neuromuscul Disord. <year>2019</year>;<volume>29</volume>(<issue>2</issue>):<fpage>97</fpage>–<lpage>107</lpage>.<pub-id pub-id-type="pmid">30679003</pub-id></mixed-citation>
</ref>
<ref id="ref031">
<label>[31]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Lanner</surname>
<given-names>JT</given-names>
</string-name>, <string-name>
<surname>Georgiou</surname>
<given-names>DK</given-names>
</string-name>, <string-name>
<surname>Joshi</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>Hamilton</surname>
<given-names>SL</given-names>
</string-name>. <article-title>Ryanodine receptors: structure, expression, molecular details, and function in calcium release</article-title>. <source/>Cold Spring Harb Perspect Biol. <year>2010</year>;<volume>2</volume>(<issue>11</issue>):<fpage>a003996</fpage>.<pub-id pub-id-type="pmid">20961976</pub-id></mixed-citation>
</ref>
<ref id="ref032">
<label>[32]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Lawal</surname>
<given-names>TA</given-names>
</string-name>, <string-name>
<surname>Todd</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Meilleur</surname>
<given-names>KG</given-names>
</string-name>. <article-title>Ryanodine Receptor 1-Related Myopathies: Diagnostic and therapeutic approaches</article-title>. <source/>Neurotherapeutics. <year>2018</year>;<volume>15</volume>(<issue>4</issue>):<fpage>885</fpage>–<lpage>99</lpage>.<pub-id pub-id-type="pmid">30406384</pub-id></mixed-citation>
</ref>
<ref id="ref033">
<label>[33]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Ferreiro</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Monnier</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Romero</surname>
<given-names>NB</given-names>
</string-name>, <string-name>
<surname>Leroy</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Bonnemann</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Haenggeli</surname>
<given-names>CA</given-names>
</string-name>, <etal>et al.</etal>
<article-title>A recessive form of central core disease, transiently presenting as multi-minicore disease, is associated with a homozygous mutation in the ryanodine receptor type 1 gene</article-title>. <source/>Ann Neurol. <year>2002</year>;<volume>51</volume>(<issue>6</issue>):<fpage>750</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">12112081</pub-id></mixed-citation>
</ref>
<ref id="ref034">
<label>[34]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Wu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ibarra</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Malicdan</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Murayama</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Ichihara</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Kikuchi</surname>
<given-names>H</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Central core disease is due to RYR1 mutations in more than 90% of patients</article-title>. <source/>Brain. <year>2006</year>;<volume>129</volume>(<issue>Pt 6</issue>):<fpage>1470</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">16621918</pub-id></mixed-citation>
</ref>
<ref id="ref035">
<label>[35]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Clarke</surname>
<given-names>NF</given-names>
</string-name>, <string-name>
<surname>Waddell</surname>
<given-names>LB</given-names>
</string-name>, <string-name>
<surname>Cooper</surname>
<given-names>ST</given-names>
</string-name>, <string-name>
<surname>Perry</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Smith</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Kornberg</surname>
<given-names>AJ</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Recessive mutations in RYR1 are a common cause of congenital fiber type disproportion</article-title>. <source/>Hum Mutat. <year>2010</year>;<volume>31</volume>(<issue>7</issue>):<fpage>E1544</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="pmid">20583297</pub-id></mixed-citation>
</ref>
<ref id="ref036">
<label>[36]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Fattori</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Maggi</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Bruno</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Cassandrini</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Codemo</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Catteruccia</surname>
<given-names>M</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Centronuclear myopathies: genotype-phenotype correlation and frequency of defined genetic forms in an Italian cohort</article-title>. <source/>J Neurol. <year>2015</year>;<volume>262</volume>(<issue>7</issue>):<fpage>1728</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="pmid">25957634</pub-id></mixed-citation>
</ref>
<ref id="ref037">
<label>[37]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Cassandrini</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Trovato</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Rubegni</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Lenzi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Fiorillo</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Baldacci</surname>
<given-names>J</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Congenital myopathies: Clinical phenotypes and new diagnostic tools</article-title>. <source/>Ital J Pediatr. <year>2017</year>;<volume>43</volume>(<issue>1</issue>):<fpage>101</fpage>.<pub-id pub-id-type="pmid">29141652</pub-id></mixed-citation>
</ref>
<ref id="ref038">
<label>[38]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Gillard</surname>
<given-names>EF</given-names>
</string-name>, <string-name>
<surname>Otsu</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Fujii</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Khanna</surname>
<given-names>VK</given-names>
</string-name>, <string-name>
<surname>de Leon</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Derdemezi</surname>
<given-names>J</given-names>
</string-name>, <etal>et al.</etal>
<article-title>A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia</article-title>. <source/>Genomics. <year>1991</year>;<volume>11</volume>(<issue>3</issue>):<fpage>751</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">1774074</pub-id></mixed-citation>
</ref>
<ref id="ref039">
<label>[39]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Dlamini</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Voermans</surname>
<given-names>NC</given-names>
</string-name>, <string-name>
<surname>Lillis</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Stewart</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kamsteeg</surname>
<given-names>EJ</given-names>
</string-name>, <string-name>
<surname>Drost</surname>
<given-names>G</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis</article-title>. <source/>Neuromuscul Disord. <year>2013</year>;<volume>23</volume>(<issue>7</issue>):<fpage>540</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">23628358</pub-id></mixed-citation>
</ref>
<ref id="ref040">
<label>[40]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Park</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Pan</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Xing</surname>
<given-names>Y</given-names>
</string-name>. <article-title>The expanding landscape of alternative splicing variation in human populations</article-title>. <source/>Am J Hum Genet. <year>2018</year>;<volume>102</volume>(<issue>1</issue>):<fpage>11</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="pmid">29304370</pub-id></mixed-citation>
</ref>
<ref id="ref041">
<label>[41]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Guo</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Bharmal</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Esbona</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Greaser</surname>
<given-names>ML</given-names>
</string-name>. <article-title>Titin diversity—alternative splicing gone wild</article-title>. <source/>J Biomed Biotechnol. <year>2010</year>;<volume>2010</volume>:<fpage>753675</fpage>.<pub-id pub-id-type="pmid">20339475</pub-id></mixed-citation>
</ref>
<ref id="ref042">
<label>[42]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Greaser</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Krzesinski</surname>
<given-names>PR</given-names>
</string-name>, <string-name>
<surname>Warren</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Kirkpatrick</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Campbell</surname>
<given-names>KS</given-names>
</string-name>, <string-name>
<surname>Moss</surname>
<given-names>RL</given-names>
</string-name>. <article-title>Developmental changes in rat cardiac titin/connectin: transitions in normal animals and in mutants with a delayed pattern of isoform transition</article-title>. <source/>J Muscle Res Cell Motil. <year>2005</year>;<volume>26</volume>(<issue>6-8</issue>):<fpage>325</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="pmid">16491431</pub-id></mixed-citation>
</ref>
<ref id="ref043">
<label>[43]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Savarese</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Jonson</surname>
<given-names>PH</given-names>
</string-name>, <string-name>
<surname>Huovinen</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Paulin</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Auvinen</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Udd</surname>
<given-names>B</given-names>
</string-name>, <etal>et al.</etal>
<article-title>The complexity of titin splicing pattern in human adult skeletal muscles</article-title>. <source/>Skelet Muscle. <year>2018</year>;<volume>8</volume>(<issue>1</issue>):<fpage>11</fpage>.<pub-id pub-id-type="pmid">29598826</pub-id></mixed-citation>
</ref>
<ref id="ref044">
<label>[44]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Laitila</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hanif</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Paetau</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hujanen</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Keto</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Somervuo</surname>
<given-names>P</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Expression of multiple nebulin isoforms in human skeletal muscle and brain</article-title>. <source/>Muscle Nerve. <year>2012</year>;<volume>46</volume>(<issue>5</issue>):<fpage>730</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">22941678</pub-id></mixed-citation>
</ref>
<ref id="ref045">
<label>[45]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Lam</surname>
<given-names>LT</given-names>
</string-name>, <string-name>
<surname>Holt</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Laitila</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hanif</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Pelin</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Wallgren-Pettersson</surname>
<given-names>C</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Two alternatively-spliced human nebulin isoforms with either exon 143 or exon 144 and their developmental regulation</article-title>. <source/>Sci Rep. <year>2018</year>;<volume>8</volume>(<issue>1</issue>):<fpage>15728</fpage>.<pub-id pub-id-type="pmid">30356055</pub-id></mixed-citation>
</ref>
<ref id="ref046">
<label>[46]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Kimura</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Nakamori</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lueck</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Pouliquin</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Aoike</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Fujimura</surname>
<given-names>H</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1</article-title>. <source/>Hum Mol Genet. <year>2005</year>;<volume>14</volume>(<issue>15</issue>):<fpage>2189</fpage>–<lpage>200</lpage>.<pub-id pub-id-type="pmid">15972723</pub-id></mixed-citation>
</ref>
<ref id="ref047">
<label>[47]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Tang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Wei</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Gu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>Z</given-names>
</string-name>, <etal>et al.</etal>
<article-title>CUG-BP1 regulates RyR1 ASI alternative splicing in skeletal muscle atrophy</article-title>. <source/>Sci Rep. <year>2015</year>;<volume>5</volume>:<fpage>16083</fpage>.<pub-id pub-id-type="pmid">26531141</pub-id></mixed-citation>
</ref>
<ref id="ref048">
<label>[48]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Guo</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Schafer</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Greaser</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Radke</surname>
<given-names>MH</given-names>
</string-name>, <string-name>
<surname>Liss</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Govindarajan</surname>
<given-names>T</given-names>
</string-name>, <etal>et al.</etal>
<article-title>RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing</article-title>. <source/>Nat Med. <year>2012</year>;<volume>18</volume>(<issue>5</issue>):<fpage>766</fpage>–<lpage>73</lpage>.<pub-id pub-id-type="pmid">22466703</pub-id></mixed-citation>
</ref>
<ref id="ref049">
<label>[49]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Bertero</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Fields</surname>
<given-names>PA</given-names>
</string-name>, <string-name>
<surname>Ramani</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Bonora</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Yardimci</surname>
<given-names>GG</given-names>
</string-name>, <string-name>
<surname>Reinecke</surname>
<given-names>H</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Dynamics of genome reorganization during human cardiogenesis reveal an RBM20-dependent splicing factory</article-title>. <source/>Nat Commun. <year>2019</year>;<volume>10</volume>(<issue>1</issue>):<fpage>1538</fpage>.<pub-id pub-id-type="pmid">30948719</pub-id></mixed-citation>
</ref>
<ref id="ref050">
<label>[50]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Richards</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Aziz</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Bale</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Bick</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Das</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Gastier-Foster</surname>
<given-names>J</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology</article-title>. <source/>Genet Med. <year>2015</year>;<volume>17</volume>(<issue>5</issue>):<fpage>405</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="pmid">25741868</pub-id></mixed-citation>
</ref>
<ref id="ref051">
<label>[51]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Delude</surname>
<given-names>CM</given-names>
</string-name>. <article-title>Deep phenotyping: The details of disease</article-title>. <source/>Nature. <year>2015</year>;<volume>527</volume>(<issue>7576</issue>):<fpage>S14</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">26536218</pub-id></mixed-citation>
</ref>
<ref id="ref052">
<label>[52]</label>
<mixed-citation publication-type="other">
<string-name>
<surname>Barp</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Laforet</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Bello</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Tasca</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Vissing</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Monforte</surname>
<given-names>M</given-names>
</string-name>, <etal>et al.</etal> European muscle MRI study in limb girdle muscular dystrophy type R1/2A (LGMDR1/LGMD2A). J Neurol. 2019.</mixed-citation>
</ref>
<ref id="ref053">
<label>[53]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>GoMez-Andres</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Diaz-Manera</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Alejaldre</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Pulido-Valdeolivas</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>GonzaLez-Mera</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Olive</surname>
<given-names>M</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Muscle imaging in laminopathies: Synthesis study identifies meaningful muscles for follow-up</article-title>. <source/>Muscle Nerve. <year>2018</year>;<volume>58</volume>(<issue>6</issue>):<fpage>812</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">30066418</pub-id></mixed-citation>
</ref>
<ref id="ref054">
<label>[54]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Alonso-Jimenez</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kroon</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Alejaldre-Monforte</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Nunez-Peralta</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Horlings</surname>
<given-names>CGC</given-names>
</string-name>, <string-name>
<surname>van Engelen</surname>
<given-names>BGM</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy</article-title>. <source/>J Neurol Neurosurg Psychiatry. <year>2019</year>;<volume>90</volume>(<issue>5</issue>):<fpage>576</fpage>–<lpage>85</lpage>.<pub-id pub-id-type="pmid">30530568</pub-id></mixed-citation>
</ref>
<ref id="ref055">
<label>[55]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Jungbluth</surname>
<given-names>H</given-names>
</string-name>. <article-title>Myopathology in times of modern imaging</article-title>. <source/>Neuropathol Appl Neurobiol. <year>2017</year>;<volume>43</volume>(<issue>1</issue>):<fpage>24</fpage>–<lpage>43</lpage>.<pub-id pub-id-type="pmid">28111795</pub-id></mixed-citation>
</ref>
<ref id="ref056">
<label>[56]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Evila</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Vihola</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Sarparanta</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Raheem</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Palmio</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Sandell</surname>
<given-names>S</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Atypical phenotypes in titinopathies explained by second titin mutations</article-title>. <source/>Ann Neurol. <year>2014</year>;<volume>75</volume>(<issue>2</issue>):<fpage>230</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="pmid">24395473</pub-id></mixed-citation>
</ref>
<ref id="ref057">
<label>[57]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Jungbluth</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Davis</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Muller</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Counsell</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Allsop</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chattopadhyay</surname>
<given-names>A</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Magnetic resonance imaging of muscle in congenital myopathies associated with RYR1 mutations</article-title>. <source/>Neuromuscul Disord. <year>2004</year>;<volume>14</volume>(<issue>12</issue>):<fpage>785</fpage>–<lpage>90</lpage>.<pub-id pub-id-type="pmid">15564033</pub-id></mixed-citation>
</ref>
<ref id="ref058">
<label>[58]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Jungbluth</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Muller</surname>
<given-names>CR</given-names>
</string-name>, <string-name>
<surname>Halliger-Keller</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Brockington</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Feng</surname>
<given-names>L</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Autosomal recessive inheritance of RYR1 mutations in a congenital myopathy with cores</article-title>. <source/>Neurology. <year>2002</year>;<volume>59</volume>(<issue>2</issue>):<fpage>284</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">12136074</pub-id></mixed-citation>
</ref>
<ref id="ref059">
<label>[59]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Jungbluth</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Sewry</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Counsell</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Allsop</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chattopadhyay</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Mercuri</surname>
<given-names>E</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Magnetic resonance imaging of muscle in nemaline myopathy</article-title>. <source/>Neuromuscul Disord. <year>2004</year>;<volume>14</volume>(<issue>12</issue>):<fpage>779</fpage>–<lpage>84</lpage>.<pub-id pub-id-type="pmid">15564032</pub-id></mixed-citation>
</ref>
<ref id="ref060">
<label>[60]</label>
<mixed-citation publication-type="other">
<string-name>
<surname>Savarese</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Johari</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Johnson</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Arumilli</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Torella</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Topf</surname>
<given-names>A</given-names>
</string-name>, <etal>et al.</etal> Improved Criteria for the Classification of Titin Variants in Inherited Skeletal Myopathies. J Neuromuscul Dis. 2020.</mixed-citation>
</ref>
<ref id="ref061">
<label>[61]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Ng</surname>
<given-names>PC</given-names>
</string-name>, <string-name>
<surname>Henikoff</surname>
<given-names>S</given-names>
</string-name>. <article-title>SIFT: Predicting amino acid changes that affect protein function</article-title>. <source/>Nucleic Acids Res. <year>2003</year>;<volume>31</volume>(<issue>13</issue>):<fpage>3812</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="pmid">12824425</pub-id></mixed-citation>
</ref>
<ref id="ref062">
<label>[62]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Adzhubei</surname>
<given-names>IA</given-names>
</string-name>, <string-name>
<surname>Schmidt</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Peshkin</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Ramensky</surname>
<given-names>VE</given-names>
</string-name>, <string-name>
<surname>Gerasimova</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bork</surname>
<given-names>P</given-names>
</string-name>, <etal>et al.</etal>
<article-title>A method and server for predicting damaging missense mutations</article-title>. <source/>Nat Methods. <year>2010</year>;<volume>7</volume>(<issue>4</issue>):<fpage>248</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">20354512</pub-id></mixed-citation>
</ref>
<ref id="ref063">
<label>[63]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Schwarz</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Cooper</surname>
<given-names>DN</given-names>
</string-name>, <string-name>
<surname>Schuelke</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Seelow</surname>
<given-names>D</given-names>
</string-name>. <article-title>MutationTaster Mutation prediction for the deep-sequencing age</article-title>. <source/>Nat Methods. <year>2014</year>;<volume>11</volume>(<issue>4</issue>):<fpage>361</fpage>–<lpage>2</lpage>.<pub-id pub-id-type="pmid">24681721</pub-id></mixed-citation>
</ref>
<ref id="ref064">
<label>[64]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Dong</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Wei</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Jian</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Gibbs</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Boerwinkle</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>K</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies</article-title>. <source/>Hum Mol Genet. <year>2015</year>;<volume>24</volume>(<issue>8</issue>):<fpage>2125</fpage>–<lpage>37</lpage>.<pub-id pub-id-type="pmid">25552646</pub-id></mixed-citation>
</ref>
<ref id="ref065">
<label>[65]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Sundaram</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Gao</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Padigepati</surname>
<given-names>SR</given-names>
</string-name>, <string-name>
<surname>McRae</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Kosmicki</surname>
<given-names>JA</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Predicting the clinical impact of human mutation with deep neural networks</article-title>. <source/>Nat Genet. <year>2018</year>;<volume>50</volume>(<issue>8</issue>):<fpage>1161</fpage>–<lpage>70</lpage>.<pub-id pub-id-type="pmid">30038395</pub-id></mixed-citation>
</ref>
<ref id="ref066">
<label>[66]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Laddach</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Gautel</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Fraternali</surname>
<given-names>F</given-names>
</string-name>. <article-title>TITINdb-a computational tool to assess titin’s role as a disease gene</article-title>. <source/>Bioinformatics. <year>2017</year>;<volume>33</volume>(<issue>21</issue>):<fpage>3482</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">29077808</pub-id></mixed-citation>
</ref>
<ref id="ref067">
<label>[67]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Kircher</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Witten</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Jain</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>O’Roak</surname>
<given-names>BJ</given-names>
</string-name>, <string-name>
<surname>Cooper</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Shendure</surname>
<given-names>J</given-names>
</string-name>. <article-title>A general framework for estimating the relative pathogenicity of human genetic variants</article-title>. <source/>Nat Genet. <year>2014</year>;<volume>46</volume>(<issue>3</issue>):<fpage>310</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">24487276</pub-id></mixed-citation>
</ref>
<ref id="ref068">
<label>[68]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Ioannidis</surname>
<given-names>NM</given-names>
</string-name>, <string-name>
<surname>Rothstein</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Pejaver</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Middha</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>McDonnell</surname>
<given-names>SK</given-names>
</string-name>, <string-name>
<surname>Baheti</surname>
<given-names>S</given-names>
</string-name>, <etal>et al.</etal>
<article-title>REVEL: An ensemble method for predicting the pathogenicity of rare missense variants</article-title>. <source/>Am J Hum Genet. <year>2016</year>;<volume>99</volume>(<issue>4</issue>):<fpage>877</fpage>–<lpage>85</lpage>.<pub-id pub-id-type="pmid">27666373</pub-id></mixed-citation>
</ref>
<ref id="ref069">
<label>[69]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Tian</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Pesaran</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Chamberlin</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Fenwick</surname>
<given-names>RB</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Gau</surname>
<given-names>CL</given-names>
</string-name>, <etal>et al.</etal>
<article-title>REVEL and BayesDel outperform other in silico meta-predictors for clinical variant classification</article-title>. <source/>Sci Rep. <year>2019</year>;<volume>9</volume>(<issue>1</issue>):<fpage>12752</fpage>.<pub-id pub-id-type="pmid">31484976</pub-id></mixed-citation>
</ref>
<ref id="ref070">
<label>[70]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Hunt</surname>
<given-names>RC</given-names>
</string-name>, <string-name>
<surname>Simhadri</surname>
<given-names>VL</given-names>
</string-name>, <string-name>
<surname>Iandoli</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sauna</surname>
<given-names>ZE</given-names>
</string-name>, <string-name>
<surname>Kimchi-Sarfaty</surname>
<given-names>C</given-names>
</string-name>. <article-title>Exposing synonymous mutations</article-title>. <source/>Trends Genet. <year>2014</year>;<volume>30</volume>(<issue>7</issue>):<fpage>308</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="pmid">24954581</pub-id></mixed-citation>
</ref>
<ref id="ref071">
<label>[71]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Cartegni</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Chew</surname>
<given-names>SL</given-names>
</string-name>, <string-name>
<surname>Krainer</surname>
<given-names>AR</given-names>
</string-name>. <article-title>Listening to silence and understanding nonsense: Exonic mutations that affect splicing</article-title>. <source/>Nat Rev Genet. <year>2002</year>;<volume>3</volume>(<issue>4</issue>):<fpage>285</fpage>–<lpage>98</lpage>.<pub-id pub-id-type="pmid">11967553</pub-id></mixed-citation>
</ref>
<ref id="ref072">
<label>[72]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Spencer</surname>
<given-names>PS</given-names>
</string-name>, <string-name>
<surname>Siller</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Anderson</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Barral</surname>
<given-names>JM</given-names>
</string-name>. <article-title>Silent substitutions predictably alter translation elongation rates and protein folding efficiencies</article-title>. <source/>J Mol Biol. <year>2012</year>;<volume>422</volume>(<issue>3</issue>):<fpage>328</fpage>–<lpage>35</lpage>.<pub-id pub-id-type="pmid">22705285</pub-id></mixed-citation>
</ref>
<ref id="ref073">
<label>[73]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Shi</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Yao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Bin</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zheng</surname>
<given-names>CH</given-names>
</string-name>, <string-name>
<surname>Xia</surname>
<given-names>J</given-names>
</string-name>. <article-title>Computational identification of deleterious synonymous variants in human genomes using a feature-based approach</article-title>. <source/>BMC Med Genomics. <year>2019</year>;<volume>12</volume>(<issue>Suppl 1</issue>):<fpage>12</fpage>.<pub-id pub-id-type="pmid">30704475</pub-id></mixed-citation>
</ref>
<ref id="ref074">
<label>[74]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Desmet</surname>
<given-names>FO</given-names>
</string-name>, <string-name>
<surname>Hamroun</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Lalande</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Collod-Beroud</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Claustres</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Beroud</surname>
<given-names>C</given-names>
</string-name>. <article-title>Human Splicing Finder: An online bioinformatics tool to predict splicing signals</article-title>. <source/>Nucleic Acids Res. <year>2009</year>;<volume>37</volume>(<issue>9</issue>):<fpage>e67</fpage>.<pub-id pub-id-type="pmid">19339519</pub-id></mixed-citation>
</ref>
<ref id="ref075">
<label>[75]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Leman</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Gaildrat</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Gac</surname>
<given-names>GL</given-names>
</string-name>, <string-name>
<surname>Ka</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Fichou</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Audrezet</surname>
<given-names>MP</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/<italic>in vitro</italic> studies: An international collaborative effort</article-title>. <source/>Nucleic Acids Res. <year>2018</year>;<volume>46</volume>(<issue>15</issue>):<fpage>7913</fpage>–<lpage>23</lpage>.<pub-id pub-id-type="pmid">29750258</pub-id></mixed-citation>
</ref>
<ref id="ref076">
<label>[76]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Jaganathan</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kyriazopoulou Panagiotopoulou</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>McRae</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Darbandi</surname>
<given-names>SF</given-names>
</string-name>, <string-name>
<surname>Knowles</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>YI</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Predicting splicing from primary sequence with deep learning</article-title>. <source/>Cell. <year>2019</year>;<volume>176</volume>(<issue>3</issue>):<fpage>535</fpage>–<lpage>48</lpage> e24.<pub-id pub-id-type="pmid">30661751</pub-id></mixed-citation>
</ref>
<ref id="ref077">
<label>[77]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Chauveau</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Bonnemann</surname>
<given-names>CG</given-names>
</string-name>, <string-name>
<surname>Julien</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Kho</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Marks</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Talim</surname>
<given-names>B</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Recessive TTN truncating mutations define novel forms of core myopathy with heart disease</article-title>. <source/>Hum Mol Genet. <year>2014</year>;<volume>23</volume>(<issue>4</issue>):<fpage>980</fpage>–<lpage>91</lpage>.<pub-id pub-id-type="pmid">24105469</pub-id></mixed-citation>
</ref>
<ref id="ref078">
<label>[78]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Hastings</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>de Villiers</surname>
<given-names>CP</given-names>
</string-name>, <string-name>
<surname>Hooper</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Ormondroyd</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Pagnamenta</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Lise</surname>
<given-names>S</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Combination of whole genome sequencing, linkage, and functional studies implicates a missense mutation in titin as a cause of autosomal dominant cardiomyopathy with features of left ventricular noncompaction</article-title>. <source/>Circ Cardiovasc Genet. <year>2016</year>;<volume>9</volume>(<issue>5</issue>):<fpage>426</fpage>–<lpage>35</lpage>.<pub-id pub-id-type="pmid">27625337</pub-id></mixed-citation>
</ref>
<ref id="ref079">
<label>[79]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Marttila</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hanif</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lemola</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Nowak</surname>
<given-names>KJ</given-names>
</string-name>, <string-name>
<surname>Laitila</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Gronholm</surname>
<given-names>M</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Nebulin interactions with actin and tropomyosin are altered by disease-causing mutations</article-title>. <source/>Skelet Muscle. <year>2014</year>;<volume>4</volume>:<fpage>15</fpage>.<pub-id pub-id-type="pmid">25110572</pub-id></mixed-citation>
</ref>
<ref id="ref080">
<label>[80]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Laitila</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lehtonen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lehtokari</surname>
<given-names>VL</given-names>
</string-name>, <string-name>
<surname>Sagath</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wallgren-Pettersson</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Gronholm</surname>
<given-names>M</given-names>
</string-name>, <etal>et al.</etal>
<article-title>A nebulin super-repeat panel reveals stronger actin binding toward the ends of the super-repeat region</article-title>. <source/>Muscle Nerve. <year>2019</year>;<volume>59</volume>(<issue>1</issue>):<fpage>116</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="pmid">30265400</pub-id></mixed-citation>
</ref>
<ref id="ref081">
<label>[81]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Tong</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>McCarthy</surname>
<given-names>TV</given-names>
</string-name>, <string-name>
<surname>MacLennan</surname>
<given-names>DH</given-names>
</string-name>. <article-title>Measurement of resting cytosolic Ca2+concentrations and Ca2+store size in HEK-293 cells transfected with malignant hyperthermia or central core disease mutant Ca2+release channels</article-title>. <source/>J Biol Chem. <year>1999</year>;<volume>274</volume>(<issue>2</issue>):<fpage>693</fpage>–<lpage>702</lpage>.<pub-id pub-id-type="pmid">9873004</pub-id></mixed-citation>
</ref>
<ref id="ref082">
<label>[82]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Tong</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Oyamada</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Demaurex</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Grinstein</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>McCarthy</surname>
<given-names>TV</given-names>
</string-name>, <string-name>
<surname>MacLennan</surname>
<given-names>DH</given-names>
</string-name>. <article-title>Caffeine and halothane sensitivity of intracellular Ca2+release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and/or central core disease</article-title>. <source/>J Biol Chem. <year>1997</year>;<volume>272</volume>(<issue>42</issue>):<fpage>26332</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">9334205</pub-id></mixed-citation>
</ref>
<ref id="ref083">
<label>[83]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Monnier</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Kozak-Ribbens</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Krivosic-Horber</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Nivoche</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Qi</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Kraev</surname>
<given-names>N</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Correlations between genotype and pharmacological, histological, functional, and clinical phenotypes in malignant hyperthermia susceptibility</article-title>. <source/>Hum Mutat. <year>2005</year>;<volume>26</volume>(<issue>5</issue>):<fpage>413</fpage>–<lpage>25</lpage>.<pub-id pub-id-type="pmid">16163667</pub-id></mixed-citation>
</ref>
<ref id="ref084">
<label>[84]</label>
<mixed-citation publication-type="other">
<string-name>
<surname>Bryen</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Ewans</surname>
<given-names>LJ</given-names>
</string-name>, <string-name>
<surname>Pinner</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>MacLennan</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Donkervoort</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Castro</surname>
<given-names>D</given-names>
</string-name>, <etal>et al.</etal> Recurrent TTN metatranscript-only c.39974-11T&gt;G splice variant associated with autosomal recessive arthrogryposis multiplex congenita and myopathy. Hum Mutat. 2019.</mixed-citation>
</ref>
<ref id="ref085">
<label>[85]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Rodenburg</surname>
<given-names>RJ</given-names>
</string-name>. <article-title>The functional genomics laboratory: Functional validation of genetic variants</article-title>. <source/>J Inherit Metab Dis. <year>2018</year>;<volume>41</volume>(<issue>3</issue>):<fpage>297</fpage>–<lpage>307</lpage>.<pub-id pub-id-type="pmid">29445992</pub-id></mixed-citation>
</ref>
<ref id="ref086">
<label>[86]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Takahashi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Yamanaka</surname>
<given-names>S</given-names>
</string-name>. <article-title>Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors</article-title>. <source/>Cell. <year>2006</year>;<volume>126</volume>(<issue>4</issue>):<fpage>663</fpage>–<lpage>76</lpage>.<pub-id pub-id-type="pmid">16904174</pub-id></mixed-citation>
</ref>
<ref id="ref087">
<label>[87]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Wang</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>McCain</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Pasqualini</surname>
<given-names>FS</given-names>
</string-name>, <string-name>
<surname>Agarwal</surname>
<given-names>A</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies</article-title>. <source/>Nat Med. <year>2014</year>;<volume>20</volume>(<issue>6</issue>):<fpage>616</fpage>–<lpage>23</lpage>.<pub-id pub-id-type="pmid">24813252</pub-id></mixed-citation>
</ref>
<ref id="ref088">
<label>[88]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Ford</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>McDonald</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Mali</surname>
<given-names>P</given-names>
</string-name>. <article-title>Functional Genomics via CRISPR-Cas</article-title>. <source/>J Mol Biol. <year>2019</year>;<volume>431</volume>(<issue>1</issue>):<fpage>48</fpage>–<lpage>65</lpage>.<pub-id pub-id-type="pmid">29959923</pub-id></mixed-citation>
</ref>
<ref id="ref089">
<label>[89]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Mali</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Esvelt</surname>
<given-names>KM</given-names>
</string-name>, <string-name>
<surname>Aach</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Guell</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>DiCarlo</surname>
<given-names>JE</given-names>
</string-name>, <etal>et al.</etal>
<article-title>RNA-guided human genome engineering via Cas9</article-title>. <source/>Science. <year>2013</year>;<volume>339</volume>(<issue>6121</issue>):<fpage>823</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">23287722</pub-id></mixed-citation>
</ref>
<ref id="ref090">
<label>[90]</label>
<mixed-citation publication-type="other">
<string-name>
<surname>Lornage</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Romero</surname>
<given-names>NB</given-names>
</string-name>, <string-name>
<surname>Grosgogeat</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Malfatti</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Donkervoort</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Marchetti</surname>
<given-names>MM</given-names>
</string-name>, <etal>et al.</etal> ACTN2 mutations cause “Multiple structured Core Disease” (MsCD). Acta Neuropathol. 2019.</mixed-citation>
</ref>
<ref id="ref091">
<label>[91]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Sarparanta</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Jonson</surname>
<given-names>PH</given-names>
</string-name>, <string-name>
<surname>Golzio</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Sandell</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Luque</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Screen</surname>
<given-names>M</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Mutations affecting the cytoplasmic functions of the co-chaperone DNAJB6 cause limb-girdle muscular dystrophy</article-title>. <source/>Nat Genet. <year>2012</year>;<volume>44</volume>(<issue>4</issue>):<fpage>450</fpage>–<lpage>5</lpage>, S1-2.<pub-id pub-id-type="pmid">22366786</pub-id></mixed-citation>
</ref>
<ref id="ref092">
<label>[92]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Hirata</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Watanabe</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hatakeyama</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Sprague</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Saint-Amant</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Nagashima</surname>
<given-names>A</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Zebrafish relatively relaxed mutants have a ryanodine receptor defect, show slow swimming and provide a model of multi-minicore disease</article-title>. <source/>Development. <year>2007</year>;<volume>134</volume>(<issue>15</issue>):<fpage>2771</fpage>–<lpage>81</lpage>.<pub-id pub-id-type="pmid">17596281</pub-id></mixed-citation>
</ref>
<ref id="ref093">
<label>[93]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Steffen</surname>
<given-names>LS</given-names>
</string-name>, <string-name>
<surname>Guyon</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Vogel</surname>
<given-names>ED</given-names>
</string-name>, <string-name>
<surname>Howell</surname>
<given-names>MH</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Weber</surname>
<given-names>GJ</given-names>
</string-name>, <etal>et al.</etal>
<article-title>The zebrafish runzel muscular dystrophy is linked to the titin gene</article-title>. <source/>Dev Biol. <year>2007</year>;<volume>309</volume>(<issue>2</issue>):<fpage>180</fpage>–<lpage>92</lpage>.<pub-id pub-id-type="pmid">17678642</pub-id></mixed-citation>
</ref>
<ref id="ref094">
<label>[94]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Telfer</surname>
<given-names>WR</given-names>
</string-name>, <string-name>
<surname>Nelson</surname>
<given-names>DD</given-names>
</string-name>, <string-name>
<surname>Waugh</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Brooks</surname>
<given-names>SV</given-names>
</string-name>, <string-name>
<surname>Dowling</surname>
<given-names>JJ</given-names>
</string-name>. <article-title>Neb: A zebrafish model of nemaline myopathy due to nebulin mutation</article-title>. <source/>Dis Model Mech. <year>2012</year>;<volume>5</volume>(<issue>3</issue>):<fpage>389</fpage>–<lpage>96</lpage>.<pub-id pub-id-type="pmid">22159874</pub-id></mixed-citation>
</ref>
<ref id="ref095">
<label>[95]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Charton</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Daniele</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Vihola</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Roudaut</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Gicquel</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Monjaret</surname>
<given-names>F</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Removal of the calpain 3 protease reverses the myopathology in a mouse model for titinopathies</article-title>. <source/>Hum Mol Genet. <year>2010</year>;<volume>19</volume>(<issue>23</issue>):<fpage>4608</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="pmid">20855473</pub-id></mixed-citation>
</ref>
<ref id="ref096">
<label>[96]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Lee</surname>
<given-names>CS</given-names>
</string-name>, <string-name>
<surname>Hanna</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Dagnino-Acosta</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Joshi</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>Knoblauch</surname>
<given-names>M</given-names>
</string-name>, <etal>et al.</etal>
<article-title>A chemical chaperone improves muscle function in mice with a RyR1 mutation</article-title>. <source/>Nat Commun. <year>2017</year>;<volume>8</volume>:<fpage>14659</fpage>.<pub-id pub-id-type="pmid">28337975</pub-id></mixed-citation>
</ref>
<ref id="ref097">
<label>[97]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Durham</surname>
<given-names>WJ</given-names>
</string-name>, <string-name>
<surname>Aracena-Parks</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Long</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Rossi</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Goonasekera</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Boncompagni</surname>
<given-names>S</given-names>
</string-name>, <etal>et al.</etal>
<article-title>RyR1 S-nitrosylation underlies environmental heat stroke and sudden death in Y522S RyR1 knockin mice</article-title>. <source/>Cell. <year>2008</year>;<volume>133</volume>(<issue>1</issue>):<fpage>53</fpage>–<lpage>65</lpage>.<pub-id pub-id-type="pmid">18394989</pub-id></mixed-citation>
</ref>
<ref id="ref098">
<label>[98]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Kushnir</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Betzenhauser</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Marks</surname>
<given-names>AR</given-names>
</string-name>. <article-title>Ryanodine receptor studies using genetically engineered mice</article-title>. <source/>FEBS Lett. <year>2010</year>;<volume>584</volume>(<issue>10</issue>):<fpage>1956</fpage>–<lpage>65</lpage>.<pub-id pub-id-type="pmid">20214899</pub-id></mixed-citation>
</ref>
<ref id="ref099">
<label>[99]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Yang</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Riehl</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Esteve</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Matthaei</surname>
<given-names>KI</given-names>
</string-name>, <string-name>
<surname>Goth</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Allen</surname>
<given-names>PD</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse</article-title>. <source/>Anesthesiology. <year>2006</year>;<volume>105</volume>(<issue>6</issue>):<fpage>1164</fpage>–<lpage>75</lpage>.<pub-id pub-id-type="pmid">17122579</pub-id></mixed-citation>
</ref>
<ref id="ref100">
<label>[100]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Laitila</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>McNamara</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Goullee</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Lawlor</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ochala</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Griffiths</surname>
<given-names>L</given-names>
</string-name>, <etal>et al.</etal>
<article-title>A mouse model with compound heterozygous nebulin mutations recapitulates the typical form of nemaline myopathy</article-title>. <source/>Neuromuscular Disorders. <year>2017</year>;<volume>27</volume>:<fpage>S183</fpage>.</mixed-citation>
</ref>
<ref id="ref101">
<label>[101]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Laitila</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>McNamara</surname>
<given-names>EL</given-names>
</string-name>, <string-name>
<surname>Wingate</surname>
<given-names>CD</given-names>
</string-name>, <string-name>
<surname>Goullee</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ross</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Taylor</surname>
<given-names>RL</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Nebulin nemaline myopathy recapitulated in a compound heterozygous mouse model with both a missense and a nonsense mutation in Neb</article-title>. <source/>Acta Neuropathol Commun. <year>2020</year>;<volume>8</volume>(<issue>1</issue>):<fpage>18</fpage>.<pub-id pub-id-type="pmid">32066503</pub-id></mixed-citation>
</ref>
<ref id="ref102">
<label>[102]</label>
<mixed-citation publication-type="other">
<string-name>
<surname>Koob</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Karanjeet</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Benzow</surname>
<given-names>K</given-names>
</string-name>. Moving human genetics into the mouse: Full human gene-replacement models. Presented at the American Society of Human Genetics 2019 Annual Meeting Houston, Texas. 2019.</mixed-citation>
</ref>
<ref id="ref103">
<label>[103]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Kosugi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Momozawa</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Terao</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Kubo</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kamatani</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Comprehensive evaluation of structural variation detection algorithms for whole genome sequencing</article-title>. <source/>Genome Biol. <year>2019</year>;<volume>20</volume>(<issue>1</issue>):<fpage>117</fpage>.<pub-id pub-id-type="pmid">31159850</pub-id></mixed-citation>
</ref>
<ref id="ref104">
<label>[104]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Truty</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Paul</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kennemer</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lincoln</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Olivares</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Nussbaum</surname>
<given-names>RL</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Prevalence and properties of intragenic copy-number variation in Mendelian disease genes</article-title>. <source/>Genet Med. <year>2019</year>;<volume>21</volume>(<issue>1</issue>):<fpage>114</fpage>–<lpage>23</lpage>.<pub-id pub-id-type="pmid">29895855</pub-id></mixed-citation>
</ref>
<ref id="ref105">
<label>[105]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Pfundt</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Del Rosario</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Vissers</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Kwint</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Janssen</surname>
<given-names>IM</given-names>
</string-name>, <string-name>
<surname>de Leeuw</surname>
<given-names>N</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Detection of clinically relevant copy-number variants by exome sequencing in a large cohort of genetic disorders</article-title>. <source/>Genet Med. <year>2017</year>;<volume>19</volume>(<issue>6</issue>):<fpage>667</fpage>–<lpage>75</lpage>.<pub-id pub-id-type="pmid">28574513</pub-id></mixed-citation>
</ref>
<ref id="ref106">
<label>[106]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Roca</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Gonzalez-Castro</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Fernandez</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Couce</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Fernandez-Marmiesse</surname>
<given-names>A</given-names>
</string-name>. <article-title>Free-access copy-number variant detection tools for targeted next-generation sequencing data</article-title>. <source/>Mutat Res. <year>2019</year>;<volume>779</volume>:<fpage>114</fpage>–<lpage>25</lpage>.<pub-id pub-id-type="pmid">31097148</pub-id></mixed-citation>
</ref>
<ref id="ref107">
<label>[107]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Mason-Suares</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Landry</surname>
<given-names>L</given-names>
</string-name>, S. <article-title>Lebo MJCGMR</article-title>. <source/>Detecting copy number variation via next generation technology. <year>2016</year>;<volume>4</volume>(<issue>3</issue>):<fpage>74</fpage>–<lpage>85</lpage>.</mixed-citation>
</ref>
<ref id="ref108">
<label>[108]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Kerkhof</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Schenkel</surname>
<given-names>LC</given-names>
</string-name>, <string-name>
<surname>Reilly</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>McRobbie</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Aref-Eshghi</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Stuart</surname>
<given-names>A</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Clinical validation of copy number variant detection from targeted next-generation sequencing panels</article-title>. <source/>J Mol Diagn. <year>2017</year>;<volume>19</volume>(<issue>6</issue>):<fpage>905</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="pmid">28818680</pub-id></mixed-citation>
</ref>
<ref id="ref109">
<label>[109]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Sadedin</surname>
<given-names>SP</given-names>
</string-name>, <string-name>
<surname>Ellis</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Masters</surname>
<given-names>SL</given-names>
</string-name>, <string-name>
<surname>Oshlack</surname>
<given-names>A</given-names>
</string-name>. <article-title>Ximmer: a system for improving accuracy and consistency of CNV calling from exome data</article-title>. <source/>Gigascience. <year>2018</year>;<volume>7</volume>(<issue>10</issue>).</mixed-citation>
</ref>
<ref id="ref110">
<label>[110]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Zhao</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Jia</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>Z</given-names>
</string-name>. <article-title>Computational tools for copy number variation (CNV) detection using next-generation sequencing data: features and perspectives</article-title>. <source/>BMC Bioinformatics. <year>2013</year>;<volume>14</volume> Suppl 11:<fpage>S1</fpage>.</mixed-citation>
</ref>
<ref id="ref111">
<label>[111]</label>
<mixed-citation publication-type="other">
<string-name>
<surname>Välipakka</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Savarese</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sagath</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Arumilli</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Giugliano</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Udd</surname>
<given-names>B</given-names>
</string-name>, <etal>et al.</etal> Improving copy number variant detection from sequencing data with a combination of programs and a predictive model. The Journal of Molecular Diagnostics. 2020;22(1):40–49.</mixed-citation>
</ref>
<ref id="ref112">
<label>[112]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Tuffery-Giraud</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Beroud</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Leturcq</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Yaou</surname>
<given-names>RB</given-names>
</string-name>, <string-name>
<surname>Hamroun</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Michel-Calemard</surname>
<given-names>L</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase</article-title>. <source/>Hum Mutat. <year>2009</year>;<volume>30</volume>(<issue>6</issue>):<fpage>934</fpage>–<lpage>45</lpage>.<pub-id pub-id-type="pmid">19367636</pub-id></mixed-citation>
</ref>
<ref id="ref113">
<label>[113]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Aartsma-Rus</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ginjaar</surname>
<given-names>IB</given-names>
</string-name>, <string-name>
<surname>Bushby</surname>
<given-names>K</given-names>
</string-name>. <article-title>The importance of genetic diagnosis for Duchenne muscular dystrophy</article-title>. <source/>J Med Genet. <year>2016</year>;<volume>53</volume>(<issue>3</issue>):<fpage>145</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="pmid">26754139</pub-id></mixed-citation>
</ref>
<ref id="ref114">
<label>[114]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Kozareva</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Stroff</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Silver</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Freidin</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Delaney</surname>
<given-names>NF</given-names>
</string-name>. <article-title>Clinical analysis of germline copy number variation in DMD using a non-conjugate hierarchical Bayesian model</article-title>. <source/>BMC Med Genomics. <year>2018</year>;<volume>11</volume>(<issue>1</issue>):<fpage>91</fpage>.<pub-id pub-id-type="pmid">30342520</pub-id></mixed-citation>
</ref>
<ref id="ref115">
<label>[115]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Välipakka</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Savarese</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Johari</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sagath</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Arumilli</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kiiski</surname>
<given-names>K</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Copy number variation analysis increases the diagnostic yield in muscle diseases</article-title>. <source/>Neurology Genetics. <year>2017</year>;<volume>3</volume>(<issue>6</issue>).</mixed-citation>
</ref>
<ref id="ref116">
<label>[116]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Kiiski</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Lehtokari</surname>
<given-names>VL</given-names>
</string-name>, <string-name>
<surname>Loytynoja</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ahlsten</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Laitila</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wallgren-Pettersson</surname>
<given-names>C</given-names>
</string-name>, <etal>et al.</etal>
<article-title>A recurrent copy number variation of the NEB triplicate region: Only revealed by the targeted nemaline myopathy CGH array</article-title>. <source/>Eur J Hum Genet. <year>2016</year>;<volume>24</volume>(<issue>4</issue>):<fpage>574</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">26197980</pub-id></mixed-citation>
</ref>
<ref id="ref117">
<label>[117]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Roggenbuck</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Rich</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Morales</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Eck</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>King</surname>
<given-names>W</given-names>
</string-name>, <etal>et al.</etal>
<article-title>A novel TTN deletion in a family with skeletal myopathy, facial weakness, and dilated cardiomyopathy</article-title>. <source/>Mol Genet Genomic Med. <year>2019</year>;<volume>7</volume>(<issue>11</issue>):<fpage>e924</fpage>.<pub-id pub-id-type="pmid">31489791</pub-id></mixed-citation>
</ref>
<ref id="ref118">
<label>[118]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Giugliano</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Savarese</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Garofalo</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Picillo</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Fiorillo</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>D’Amico</surname>
<given-names>A</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Copy Number Variants Account for a Tiny Fraction of Undiagnosed Myopathic Patients</article-title>. <source/>Genes (Basel). <year>2018</year>;<volume>9</volume>(<issue>11</issue>).</mixed-citation>
</ref>
<ref id="ref119">
<label>[119]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Savarese</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Musumeci</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Giugliano</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Rubegni</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Fiorillo</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Fattori</surname>
<given-names>F</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Novel findings associated with MTM1 suggest a higher number of female symptomatic carriers</article-title>. <source/>Neuromuscul Disord. <year>2016</year>;<volume>26</volume>(<issue>4-5</issue>):<fpage>292</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">27017278</pub-id></mixed-citation>
</ref>
<ref id="ref120">
<label>[120]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Tian</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Liang</surname>
<given-names>WC</given-names>
</string-name>, <string-name>
<surname>Feng</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>VW</given-names>
</string-name>, <string-name>
<surname>Chou</surname>
<given-names>CH</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Expanding genotype/phenotype of neuromuscular diseases by comprehensive target capture/NGS</article-title>. <source/>Neurology Genetics. <year>2015</year>;<volume>1</volume>(<issue>2</issue>):<fpage>e14</fpage>.<pub-id pub-id-type="pmid">27066551</pub-id></mixed-citation>
</ref>
<ref id="ref121">
<label>[121]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Piluso</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Dionisi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Del Vecchio Blanco</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Torella</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Aurino</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Savarese</surname>
<given-names>M</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Motor chip: a comparative genomic hybridization microarray for copy-number mutations in 245 neuromuscular disorders</article-title>. <source/>Clin Chem. <year>2011</year>;<volume>57</volume>(<issue>11</issue>):<fpage>1584</fpage>–<lpage>96</lpage>.<pub-id pub-id-type="pmid">21896784</pub-id></mixed-citation>
</ref>
<ref id="ref122">
<label>[122]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Giugliano</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Fanin</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Savarese</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Piluso</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Angelini</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Nigro</surname>
<given-names>V</given-names>
</string-name>. <article-title>Identification of an intragenic deletion in the SGCB gene through a re-evaluation of negative next generation sequencing results</article-title>. <source/>Neuromuscul Disord. <year>2016</year>;<volume>26</volume>(<issue>6</issue>):<fpage>367</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">27108072</pub-id></mixed-citation>
</ref>
<ref id="ref123">
<label>[123]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Fichna</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Macias</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Piechota</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Korostynski</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Potulska-Chromik</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Redowicz</surname>
<given-names>MJ</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Whole-exome sequencing identifies novel pathogenic mutations and putative phenotype-influencing variants in Polish limb-girdle muscular dystrophy patients</article-title>. <source/>Hum Genomics. <year>2018</year>;<volume>12</volume>(<issue>1</issue>):<fpage>34</fpage>.<pub-id pub-id-type="pmid">29970176</pub-id></mixed-citation>
</ref>
<ref id="ref124">
<label>[124]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Nowakowska</surname>
<given-names>B</given-names>
</string-name>. <article-title>Clinical interpretation of copy number variants in the human genome</article-title>. <source/>J Appl Genet. <year>2017</year>;<volume>58</volume>(<issue>4</issue>):<fpage>449</fpage>–<lpage>57</lpage>.<pub-id pub-id-type="pmid">28963714</pub-id></mixed-citation>
</ref>
<ref id="ref125">
<label>[125]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Haraksingh</surname>
<given-names>RR</given-names>
</string-name>, <string-name>
<surname>Abyzov</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Gerstein</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Urban</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Snyder</surname>
<given-names>M</given-names>
</string-name>. <article-title>Genome-wide mapping of copy number variation in humans: comparative analysis of high resolution array platforms</article-title>. <source/>PLoS One. <year>2011</year>;<volume>6</volume>(<issue>11</issue>):<fpage>e27859</fpage>.<pub-id pub-id-type="pmid">22140474</pub-id></mixed-citation>
</ref>
<ref id="ref126">
<label>[126]</label>
<mixed-citation publication-type="other">
<string-name>
<surname>Riggs</surname>
<given-names>ER</given-names>
</string-name>, <string-name>
<surname>Andersen</surname>
<given-names>EF</given-names>
</string-name>, <string-name>
<surname>Cherry</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Kantarci</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kearney</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Patel</surname>
<given-names>A</given-names>
</string-name>, <etal>et al.</etal> Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2019.</mixed-citation>
</ref>
<ref id="ref127">
<label>[127]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Cummings</surname>
<given-names>BB</given-names>
</string-name>, <string-name>
<surname>Marshall</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Tukiainen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Lek</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Donkervoort</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Foley</surname>
<given-names>AR</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Improving genetic diagnosis in Mendelian disease with transcriptome sequencing</article-title>. <source/>Sci Transl Med. <year>2017</year>;<volume>9</volume>(<issue>386</issue>).</mixed-citation>
</ref>
<ref id="ref128">
<label>[128]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Gonorazky</surname>
<given-names>HD</given-names>
</string-name>, <string-name>
<surname>Naumenko</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ramani</surname>
<given-names>AK</given-names>
</string-name>, <string-name>
<surname>Nelakuditi</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Mashouri</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>P</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Expanding the Boundaries of RNA Sequencing as a Diagnostic Tool for Rare Mendelian Disease</article-title>. <source/>Am J Hum Genet. <year>2019</year>;<volume>104</volume>(<issue>3</issue>):<fpage>466</fpage>–<lpage>83</lpage>.<pub-id pub-id-type="pmid">30827497</pub-id></mixed-citation>
</ref>
<ref id="ref129">
<label>[129]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Lee</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Jonson</surname>
<given-names>PH</given-names>
</string-name>, <string-name>
<surname>Sarparanta</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Palmio</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Sarkar</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Vihola</surname>
<given-names>A</given-names>
</string-name>, <etal>et al.</etal>
<article-title>TIA1 variant drives myodegeneration in multisystem proteinopathy with SQSTM1 mutations</article-title>. <source/>J Clin Invest. <year>2018</year>;<volume>128</volume>(<issue>3</issue>):<fpage>1164</fpage>–<lpage>77</lpage>.<pub-id pub-id-type="pmid">29457785</pub-id></mixed-citation>
</ref>
<ref id="ref130">
<label>[130]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>D’Amico</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Fattori</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Tasca</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Petrini</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Gualandi</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Bruselles</surname>
<given-names>A</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Somatic mosaicism represents an underestimated event underlying collagen 6-related disorders</article-title>. <source/>Eur J Paediatr Neurol. <year>2017</year>;<volume>21</volume>(<issue>6</issue>):<fpage>873</fpage>–<lpage>83</lpage>.<pub-id pub-id-type="pmid">28760337</pub-id></mixed-citation>
</ref>
<ref id="ref131">
<label>[131]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Donkervoort</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Stojkovic</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Voermans</surname>
<given-names>NC</given-names>
</string-name>, <string-name>
<surname>Foley</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Leach</surname>
<given-names>ME</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Mosaicism for dominant collagen 6 mutations as a cause for intrafamilial phenotypic variability</article-title>. <source/>Hum Mutat. <year>2015</year>;<volume>36</volume>(<issue>1</issue>):<fpage>48</fpage>–<lpage>56</lpage>.<pub-id pub-id-type="pmid">25204870</pub-id></mixed-citation>
</ref>
<ref id="ref132">
<label>[132]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Pehlivan</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Bayram</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Gunes</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Coban Akdemir</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Shukla</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bierhals</surname>
<given-names>T</given-names>
</string-name>, <etal>et al.</etal>
<article-title>The Genomics of Arthrogryposis, a Complex Trait: Candidate Genes and Further Evidence for Oligogenic Inheritance</article-title>. <source/>Am J Hum Genet. <year>2019</year>;<volume>105</volume>(<issue>1</issue>):<fpage>132</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="pmid">31230720</pub-id></mixed-citation>
</ref>
<ref id="ref133">
<label>[133]</label>
<mixed-citation publication-type="other">
<string-name>
<surname>Lee</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>AY</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>LK</given-names>
</string-name>, <string-name>
<surname>Yoon</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Renteria</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Eskin</surname>
<given-names>A</given-names>
</string-name>, <etal>et al.</etal> Diagnostic utility of transcriptome sequencing for rare Mendelian diseases. Genet Med. 2019.</mixed-citation>
</ref>
<ref id="ref134">
<label>[134]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Hamanaka</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Miyatake</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Koshimizu</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Tsurusaki</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Mitsuhashi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Iwama</surname>
<given-names>K</given-names>
</string-name>, <etal>et al.</etal>
<article-title>RNA sequencing solved the most common but unrecognized NEB pathogenic variant in Japanese nemaline myopathy</article-title>. <source/>Genet Med. <year>2019</year>;<volume>21</volume>(<issue>7</issue>):<fpage>1629</fpage>–<lpage>38</lpage>.<pub-id pub-id-type="pmid">30467404</pub-id></mixed-citation>
</ref>
<ref id="ref135">
<label>[135]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Greer</surname>
<given-names>SU</given-names>
</string-name>, <string-name>
<surname>Nadauld</surname>
<given-names>LD</given-names>
</string-name>, <string-name>
<surname>Lau</surname>
<given-names>BT</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wood-Bouwens</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Ford</surname>
<given-names>JM</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Linked read sequencing resolves complex genomic rearrangements in gastric cancer metastases</article-title>. <source/>Genome Med. <year>2017</year>;<volume>9</volume>(<issue>1</issue>):<fpage>57</fpage>.<pub-id pub-id-type="pmid">28629429</pub-id></mixed-citation>
</ref>
<ref id="ref136">
<label>[136]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Marks</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Garcia</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Barrio</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Belhocine</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Bernate</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Bharadwaj</surname>
<given-names>R</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Resolving the full spectrum of human genome variation using Linked-Reads</article-title>. <source/>Genome Res. <year>2019</year>;<volume>29</volume>(<issue>4</issue>):<fpage>635</fpage>–<lpage>45</lpage>.<pub-id pub-id-type="pmid">30894395</pub-id></mixed-citation>
</ref>
<ref id="ref137">
<label>[137]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Pollard</surname>
<given-names>MO</given-names>
</string-name>, <string-name>
<surname>Gurdasani</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Mentzer</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Porter</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Sandhu</surname>
<given-names>MS</given-names>
</string-name>. <article-title>Long reads: their purpose and place</article-title>. <source/>Hum Mol Genet. <year>2018</year>;<volume>27</volume>(<issue>R2</issue>):<fpage>R234</fpage>–<lpage>R41</lpage>.<pub-id pub-id-type="pmid">29767702</pub-id></mixed-citation>
</ref>
<ref id="ref138">
<label>[138]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Jang</surname>
<given-names>SS</given-names>
</string-name>, <string-name>
<surname>Lim</surname>
<given-names>BC</given-names>
</string-name>, <string-name>
<surname>Yoo</surname>
<given-names>SK</given-names>
</string-name>, <string-name>
<surname>Shin</surname>
<given-names>JY</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>KJ</given-names>
</string-name>, <string-name>
<surname>Seo</surname>
<given-names>JS</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Targeted linked-read sequencing for direct haplotype phasing of maternal DMD alleles: a practical and reliable method for noninvasive prenatal diagnosis</article-title>. <source/>Sci Rep. <year>2018</year>;<volume>8</volume>(<issue>1</issue>):<fpage>8678</fpage>.<pub-id pub-id-type="pmid">29875376</pub-id></mixed-citation>
</ref>
<ref id="ref139">
<label>[139]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Di Fruscio</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Garofalo</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Mutarelli</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Savarese</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nigro</surname>
<given-names>V</given-names>
</string-name>. <article-title>Are all the previously reported genetic variants in limb girdle muscular dystrophy genes pathogenic?</article-title>
<source/>Eur J Hum Genet. <year>2016</year>;<volume>24</volume>(<issue>1</issue>):<fpage>73</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">25898921</pub-id></mixed-citation>
</ref>
<ref id="ref140">
<label>[140]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Andreasen</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Nielsen</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Refsgaard</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Holst</surname>
<given-names>AG</given-names>
</string-name>, <string-name>
<surname>Christensen</surname>
<given-names>AH</given-names>
</string-name>, <string-name>
<surname>Andreasen</surname>
<given-names>L</given-names>
</string-name>, <etal>et al.</etal>
<article-title>New population-based exome data are questioning the pathogenicity of previously cardiomyopathy-associated genetic variants</article-title>. <source/>Eur J Hum Genet. <year>2013</year>;<volume>21</volume>(<issue>9</issue>):<fpage>918</fpage>–<lpage>28</lpage>.<pub-id pub-id-type="pmid">23299917</pub-id></mixed-citation>
</ref>
<ref id="ref141">
<label>[141]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Liu</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Meng</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Normand</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Xia</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Ghazi</surname>
<given-names>A</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Reanalysis of clinical exome sequencing data</article-title>. <source/>N Engl J Med. <year>2019</year>;<volume>380</volume>(<issue>25</issue>):<fpage>2478</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">31216405</pub-id></mixed-citation>
</ref>
<ref id="ref142">
<label>[142]</label>
<mixed-citation publication-type="other">
<string-name>
<surname>Appelbaum</surname>
<given-names>PS</given-names>
</string-name>, <string-name>
<surname>Parens</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Berger</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Chung</surname>
<given-names>WK</given-names>
</string-name>, <string-name>
<surname>Burke</surname>
<given-names>W</given-names>
</string-name>. Is there a duty to reinterpret genetic data? The ethical dimensions. Genet Med. 2019.</mixed-citation>
</ref>
<ref id="ref143">
<label>[143]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Brnich</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Abou Tayoun</surname>
<given-names>AN</given-names>
</string-name>, <string-name>
<surname>Couch</surname>
<given-names>FJ</given-names>
</string-name>, <string-name>
<surname>Cutting</surname>
<given-names>GR</given-names>
</string-name>, <string-name>
<surname>Greenblatt</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Heinen</surname>
<given-names>CD</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework</article-title>. <source/>Genome Med. <year>2019</year>;<volume>12</volume>(<issue>1</issue>):<fpage>3</fpage>.<pub-id pub-id-type="pmid">31892348</pub-id></mixed-citation>
</ref>
<ref id="ref144">
<label>[144]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Gelman</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Dines</surname>
<given-names>JN</given-names>
</string-name>, <string-name>
<surname>Berg</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Berger</surname>
<given-names>AH</given-names>
</string-name>, <string-name>
<surname>Brnich</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hisama</surname>
<given-names>FM</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Recommendations for the collection and use of multiplexed functional data for clinical variant interpretation</article-title>. <source/>Genome Med. <year>2019</year>;<volume>11</volume>(<issue>1</issue>):<fpage>85</fpage>.<pub-id pub-id-type="pmid">31862013</pub-id></mixed-citation>
</ref>
<ref id="ref145">
<label>[145]</label>
<mixed-citation publication-type="other">
<string-name>
<surname>Kelly</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Caleshu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Morales</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Buchan</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wolf</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Harrison</surname>
<given-names>SM</given-names>
</string-name>, <etal>et al.</etal> Adaptation and validation of the ACMG/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: Recommendations by ClinGen’s Inherited Cardiomyopathy Expert Panel. Genet Med. 2018.</mixed-citation>
</ref>
<ref id="ref146">
<label>[146]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Karaca</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Posey</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Coban Akdemir</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Pehlivan</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Harel</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Jhangiani</surname>
<given-names>SN</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Phenotypic expansion illuminates multilocus pathogenic variation</article-title>. <source/>Genet Med. <year>2018</year>;<volume>20</volume>(<issue>12</issue>):<fpage>1528</fpage>–<lpage>37</lpage>.<pub-id pub-id-type="pmid">29790871</pub-id></mixed-citation>
</ref>
<ref id="ref147">
<label>[147]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Hackman</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Udd</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Bonnemann</surname>
<given-names>CG</given-names>
</string-name>, <string-name>
<surname>Ferreiro</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Titinopathy Database</surname>
<given-names>C</given-names>
</string-name>. <article-title>219th ENMC International Workshop Titinopathies International database of titin mutations and phenotypes, Heemskerk, The Netherlands, 29 April-1 May 2016</article-title>. <source/>Neuromuscul Disord. <year>2017</year>;<volume>27</volume>(<issue>4</issue>):<fpage>396</fpage>–<lpage>407</lpage>.<pub-id pub-id-type="pmid">28214268</pub-id></mixed-citation>
</ref>
<ref id="ref148">
<label>[148]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Boycott</surname>
<given-names>KM</given-names>
</string-name>, <string-name>
<surname>Rath</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Chong</surname>
<given-names>JX</given-names>
</string-name>, <string-name>
<surname>Hartley</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Alkuraya</surname>
<given-names>FS</given-names>
</string-name>, <string-name>
<surname>Baynam</surname>
<given-names>G</given-names>
</string-name>, <etal>et al.</etal>
<article-title>International cooperation to enable the diagnosis of all rare genetic diseases</article-title>. <source/>Am J Hum Genet. <year>2017</year>;<volume>100</volume>(<issue>5</issue>):<fpage>695</fpage>–<lpage>705</lpage>.<pub-id pub-id-type="pmid">28475856</pub-id></mixed-citation>
</ref>
<ref id="ref149">
<label>[149]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Lochmuller</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Badowska</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Thompson</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Knoers</surname>
<given-names>NV</given-names>
</string-name>, <string-name>
<surname>Aartsma-Rus</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Gut</surname>
<given-names>I</given-names>
</string-name>, <etal>et al.</etal>
<article-title>RD-Connect, NeurOmics and EURenOmics: Collaborative European initiative for rare diseases</article-title>. <source/>Eur J Hum Genet. <year>2018</year>;<volume>26</volume>(<issue>6</issue>):<fpage>778</fpage>–<lpage>85</lpage>.<pub-id pub-id-type="pmid">29487416</pub-id></mixed-citation>
</ref>
<ref id="ref150">
<label>[150]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Lochmuller</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Torrent</surname>
<given-names>IFJ</given-names>
</string-name>, <string-name>
<surname>Le Cam</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Jonker</surname>
<given-names>AH</given-names>
</string-name>, <string-name>
<surname>Lau</surname>
<given-names>LP</given-names>
</string-name>, <string-name>
<surname>Baynam</surname>
<given-names>G</given-names>
</string-name>, <etal>et al.</etal>
<article-title>The International Rare Diseases Research Consortium: Policies and Guidelines to maximize impact</article-title>. <source/>Eur J Hum Genet. <year>2017</year>;<volume>25</volume>(<issue>12</issue>):<fpage>1293</fpage>–<lpage>302</lpage>.<pub-id pub-id-type="pmid">29158551</pub-id></mixed-citation>
</ref>
<ref id="ref151">
<label>[151]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Landrum</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Benson</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>GR</given-names>
</string-name>, <string-name>
<surname>Chao</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Chitipiralla</surname>
<given-names>S</given-names>
</string-name>, <etal>et al.</etal>
<article-title>ClinVar: Improving access to variant interpretations and supporting evidence</article-title>. <source/>Nucleic Acids Res. <year>2018</year>;<volume>46</volume>(<issue>D1</issue>):<fpage>D1062</fpage>–<lpage>D7</lpage>.<pub-id pub-id-type="pmid">29165669</pub-id></mixed-citation>
</ref>
<ref id="ref152">
<label>[152]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Fokkema</surname>
<given-names>IF</given-names>
</string-name>, <string-name>
<surname>Taschner</surname>
<given-names>PE</given-names>
</string-name>, <string-name>
<surname>Schaafsma</surname>
<given-names>GC</given-names>
</string-name>, <string-name>
<surname>Celli</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Laros</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>den Dunnen</surname>
<given-names>JT</given-names>
</string-name>. <article-title>LOVD v.2.0: The next generation in gene variant databases</article-title>. <source/>Hum Mutat. <year>2011</year>;<volume>32</volume>(<issue>5</issue>):<fpage>557</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="pmid">21520333</pub-id></mixed-citation>
</ref>
<ref id="ref153">
<label>[153]</label>
<mixed-citation publication-type="journal">
<string-name>
<surname>Amendola</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Jarvik</surname>
<given-names>GP</given-names>
</string-name>, <string-name>
<surname>Leo</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>McLaughlin</surname>
<given-names>HM</given-names>
</string-name>, <string-name>
<surname>Akkari</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Amaral</surname>
<given-names>MD</given-names>
</string-name>, <etal>et al.</etal>
<article-title>Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium</article-title>. <source/>Am J Hum Genet. <year>2016</year>;<volume>98</volume>(<issue>6</issue>):<fpage>1067</fpage>–<lpage>76</lpage>.<pub-id pub-id-type="pmid">27181684</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>